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 The interest in magnetic nanoparticles is multi-dimensional. Fundamentally, it is 
important to be able to control their magnetic properties and to correlate to specific 
applications. In biology, magnetic nanoparticles offer promising potential as magnetic 
carriers or “chaperones” for magnetic localization and manipulation of therapeutic 
reagents.  
The synthesis of superparamagnetic CoFe2-xSmxO4 nanoparticles and the 
tunability of their magnetic properties by size and composition variations are discussed. 
An increase in size of CoSm0.19Fe1.81O4 nanoparticles produced an increase in blocking 
temperature and saturation magnetization, but a non-linear coercitivity response was 
observed with change in size. By varying the composition, the saturation magnetization 
of CoFe2-xSmxO4 decreased dramatically while the coercitivity increased when compared 
to native cobalt spinel ferrite (CoFe2O4) nanoparticles. These results demonstrate how the 
magnetic properties of cobalt spinel ferrite nanoparticles can be tailored to specific 
applications.  
Surface modifications of cobalt spinel ferrite nanoparticles facilitated the 
conjugation of oligonucleotides. Using a transfection reagent, CoFe2O4 – oligonucleotide 
 xviii
conjugates were delivered into mammalian cells. Post transfection, synchronized 
movement of cells in response to an external magnetic field was observed. This 
demonstrated the possibility of magnetic manipulation and localization of therapeutic 
reagents coupled to CoFe2O4 magnetic nanoparticles.  
Results from this thesis demonstrate the potential role of magnetic spinel 













 One of the first documented encounters with a magnetic material was made by 
Magnes, a Greek shepherd, around 900 B.C.1 While walking across a field with an 
abundant amount of black stones, the iron tip of his staff struck one of these stones and he 
observed that the nails in his hobnail boots were being pulled out of their place by these 
stones.1,2 These black stones are lodestones, comprised of the mineral magnetite (Fe3O4). 
They were also referred to as the bones of Haroeri, grandson of the earth goddess, by 
ancient Egyptians.2 The magnetism phenomenon had many early explanations that lacked 
sound concepts. For example, Thales (636-546 B.C.), a Greek philosopher, explained that 
the lodestones had a soul just like animals.1,2 It was discovered that a lodestone carved 
into the shape of a spoon sitting on a polished bronze plate had been used as a South 
pointing device invented by the Chinese around 200 B. C.1,2 However, it was not until 
1600 A.D. that modern concepts of magnetism evolved. Dr. William Gilbert, court 
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physician to Queen Elizabeth I of England, systematically studied and documented 
(~1600 A. D.) that the entire world is a big magnet.1 Since then, a number of historical 





1920s Physics of magnetism develops incorporating electron spins and 
exchange interactions  
1905 Theory of diagmagnetism and paramagnetism  
1906 Ferromagnetic theory proposed  
1895 Curie Law proposed 
1880 First hysteresis loop for iron 
1825 Electromagnet invented 
1819 The connection between magnetism and electricity is made 
 
Contributions after Gilbert’s conclusion, “magnus magnes ipse est globus 
terrestris” 




 The drive to miniaturize magnetic materials and to develop novel materials often 
involves scaling down to nanometers. The magnetic behavior of nanoparticles differs 
dramatically from their bulk counterparts.2-4 In bulk material, the magnetic behavior is 
influenced by domains and domain walls (See figure 1.2). Magnetic domains are regions 
in a crystal where the magnetic moment orientation is different but aligns with the easy 
axis and each domain is separated by a thin domain wall.3,4 Magnetic nanoparticles that 
are small enough, are single domained. Magnetic domains exist to reduce the energy of 
the system but when the size of  magnetic nanoparticles decrease to a critical size, Dc, it 
can no longer support multiple domains and it exhibits interesting single domain 
behavior.3,4 In this chapter, the fundamentals of magnetism, and single domain behavior, 
as well as superparamagnetism are briefly reviewed. Since it is impossible to list all of 
the applications in which magnetic nanoparticles can be utilized, an overview of some of 








Figure 1.2 Schematic representation of domains and domain walls in bulk materials.  
 3
1.2 Brief Review of Magnetism 
 
1.2.1 Fundamentals  
 
  There is an intimate relationship between magnetism and electricity. A magnetic 
field is produced when there are electrical charges moving.2,5-8 In an atom, when 
electrons circulate the nucleus, an orbital magnetic moment is produced. Associated with 
this is the spin magnetic moment produced by electrons spinning about its own axis. 
When a material is placed under a magnetic field, the magnetic induction or the flux of 
magnetic lines through a cross-sectional area of the material can be represented by  
 
                                                         B = H + 4πM                                                          (1.1) 
 
where B is the magnetic induction, H is the applied magnetic field, and M is the 
magnetization in response to the field.5,8 The susceptibility and permeability of a material 
is also an important factor that relates information such as the type of magnetic material 
(paramagnetic, diamagnetic, etc.) and the strength of the magnetic effect associated with 
a particular magnetic material.6 Essentially, the susceptibility, χ, is the ratio of 
magnetization and the applied field (see equation 1.2).2,5-8  
 




The permeability, µ, of the material is given by  
 
                                                            µ = B/H                                                                (1.3) 
 
and the susceptibility and permeability can be related by  
 
                                                            µ = µ0 (1+ χ)                                                        (1.4)  
 
where µ0 is the permeability under vacuum.2,5-8 In the study of magnetic properties, the 
susceptibility parameter is the main characterization parameter since it describes the 
response of a material with an applied magnetic field. Since magnetism interconnects 
chemistry, physics, and material science, it is worth pointing out that there are two unit 
























factors from cgs 
to SI unit 
B G T 10-4
H Oe A/m 103/4π 
M emu/cm3 A/m 103
4πm G ---- ---- 
µ Dimensionless H/m 4π x 10-7-







 Magnetic materials can be categorized as diamagnetic, paramagnetic, 
ferromagnetic, antiferromagnetic, or ferrimagnetic.1,4-6,9,10 The two most common 
classification that account for most of the elements in the periodic table are either 
diamagnetic or paramagnetic (see Figure 1.3).5,6,10 Diamagnetic materials do not have 
any unpaired electrons. Hence, there is no net moment in diamagnetic materials (Figure 
1.4a). In response to an  applied field, diamagnetic materials produce a weak 
 6
magnetization that opposes the applied field giving rise to a negative susceptibility. In 
paramagnetic materials, the magnetic moments are randomly oriented due to thermal 
agitation (Figure 1.4b). From the Curie Law (equation 1.5), we can see that the magnetic 
ordering of paramagnetic materials is influenced by temperature.5,8,10 
 
                                             χ = C/T  (C =  the Currie Constant)                                   (1.5) 
 
Although magnetic moments in paramagnetic materials do not interact with each other, 
the Curie Law states that with increasing temperature, thermal agitation increases making 
the moments harder to align.5,8,10 Hence, there is a small but positive susceptibility. The 
magnetic moments in ferromagnetic materials are aligned in parallel (Figure 1.4c). Due 
to their magnetic ordering, ferromagnetic materials exhibit magnetization even in the 
absence of a magnetic field. At or above the transition or Curie temperature (Tc), the 
magnetic ordering follows the Curie Weiss Law (equation 1.6) 
 
 
                                                χ = C/(T-θ)  (θ = the Weiss constant)                             (1.6)  
 
and moments becomes randomly oriented, behaving like paramagnetic materials.5,8,10 
Materials that are antiferromagnetic are similar to ferromagnetic materials. However, due 
to their exchange interaction between neighboring atoms, their magnetic moments are 
aligned anti-parallel to each other.5,8,10 Above the transition temperature, (Neel 
temperature, TN) moments cancel out and orient themselves the same way paramagnetic 
 7
materials do.5,8,10 Similar to antiferromagnetic materials, the magnetic ordering of 
ferrimagnetic materials are anti-parallel but have different magnitudes or the number of 
anti-parallel moments is unequal. A summary of the different magnetic material and their 


















Figure 1.4 Magnetic moment ordering in (a) diamagnetics, (b) paramagnetics, (c) 
ferromagnetics, (d) antiferromagnetics, and (e) ferrimagnetics. 
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Table 1.2 Summary of the magnetic behavior of different magnetic materials.9 
Types of 
Magnetism 
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1.3.1 Single Domain Behavior 
 
 In bulk magnetic materials, magnetic domains or large regions (up to several 
hundred nanometers in diameter) with uniform magnetization, separated by domain walls, 
exist to reduce the energy of the system.4,11  Movement and nucleation of the domain 
walls minimizes the magnetostatic energy (see figure 1.5). When the size of the magnetic 
material decreases to a critical size (up to several hundred nanometer in diameter), the 
amount of energy to produce domain walls becomes greater than the reduction in 
magnetostatic energy making it unfavorable to support multiple domains. As a 
consequence, only a single domain is formed and supported. In a single domain system, 
the reversal of magnetization no longer occurs through domain wall motion but requires 
coherent rotation of the spins, resulting in larger coercitivities. The existence of single 
domain in particles was first predicted by Frenkel and Dorfman12 in 1930 but it was well 
over a decade before Kittel11 provided the first estimate of the critical size for single 
domain formation. This critical size can be estimated based on equation 1.711,13 
 
     Dcr = 35 (KA)1/2 / µoMs2                                        (1.7) 
 
where Dcr is the critical diameter, K is the anisotropy energy density, A is the exchange 









Figure 1.5. Schematic representation of domain wall moving as an external field is 




 Through experimental observations, Kittel11 summarized that the Ms of single 
domain ferromagnetic particles are unidirectional and magnetization changes only occur 
through spin rotation leading to high coercive forces since the spin rotation is opposed by 
anisotropy forces. In addition, Kittel11 describes that the magnetization changes occurring 
at weak magnetic fields may be due to reversible spin rotation associated with a low 
initial permeability. Hence, Dc can be heavily influenced by Ms, K, and A.  Although the 
range of Dcr can cover between 10-800nm, most of the critical diameters for common 
magnetic nanoparticles are below or around 100nm. For example, the Dc of Co is 70nm 
 12





Table 1.3 Examples of critical diameters of some common magnetic materials.4,14  













 Superparmagnetism, a term coined by Bean, is unique to magnetic 
nanoparticles.15,16 When the size of magnetic nanoparticle decreases below the Dc, 
magnetic moments become increasingly influenced by thermal fluctuation and the system 
becomes superparamagnetic. As a consequence there is an unstable magnetization and the 
 13
coercitivity approaches zero (see Figure 1.6). In superparamagnetic systems, the 
temperature at which moments are blocked or unable to relax is referred to as the 
blocking temperature, TB. Above the TB, moments can align with any crystallographic 
direction and behave like paramagnetic material but with much greater moments.4,15-17  
The criteria for superparamagnetism classification are (1) absence of hysteresis above 
their blocking temperature and (2) M vs. T must superpose M vs. H/T.4  Like other 
magnetic material, the magnetization behavior of superparamagnetic nanoparticles can be 
influenced by anisotropic factors such as shape, stress, exchange, and crystal anisotropy. 
Shape anisotropy and crystal anisotropy are the two most common anisotropy effects and 
will be briefly overviewed in the following sections. For detailed development on 
superparmagnetism, please refer to classic reviews by Bean and Livingston16 as well as 





Figure 1.6 Correlation between particle size and domain classification and coercitivity.4 
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1.3.3 Stoner-Wohlfarth Theory and Néel Theory 
 
 One of the most recognized theories describing the assembly of non-interacting 
single domain magnetic nanoparticles with uniaxial anisotropy is the Stoner-Wohlfarth 
theory.18 The simplest form to represent the energy barrier for magnetization reversal in 
single domain magnetic nanoparticles is by          
 
         EA = KV sin2θ                                                  (1.8) 
 
where EA is the activation energy, K is the magnetic anisotropy of the nanoparticle, V is 
the volume of the nanoparticle,  and θ is the angle between the easy axis and the moment 
of the nanoparticle.18 Schematically, we can picture the EA as the activation barrier in a 
potential well where the reversal of the moments requires overcoming the EA with each 
minima (there are multiple) corresponding to different crystallographic directions (Figure 






Figure 1.7 Schematic representation of energy barrier for magnetization reversal. 
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 In 1949, Néel theorized that there is a time dependence on the reversal of 
magnetization.19 This magnetic behavior is dependent on the relaxation time (τ) of the 
system and is given by equation 1.9 
 
        τ = τo exp [KV/(kBT)]    (1.9)
 
where τo is the frequency for magnetization vectors to flip, kB is the Boltzmann’s 
constant, and T is the temperature.19 Although factors such as temperature, saturation 
magnetization, applied magnetic field, and volume of the particle can all affect τo, they 
are usually constant and are in the order of 10-9 – 10-13.20-23 Relating this concept back to 
superparamagnetism, if the measurement time is shorter than τ then moments are blocked 
but if the measurement time is longer thanτ, moments are no longer blocked and particles 
become superparamagnetic. As an example, taking an arbitrary measurement time of 
100s and τo = 10-9s, the condition for superparamagnetism becomes: 
 
            KV = kBT              (1.10) 
 
with KV = 25 kBT for superparamagnetic conditions. When thermal energy is greater 
than EA, coherent magnetization reversal occurs and the moments fluctuate to random 
crystallographic axes leading to paramagnetic behavior. Since each moment in 
superparamagnetic nanoparticles is coupled to many others, the moment per particle is 





 As previously mentioned, two common anisotropy factors that influence the 
magnetic behavior of superparamagnetic nanoparticles are shape anisotropy and 
crystallographic anisotropy.4 Shape anisotropy arises from magnetostatic effects. It is 
predicted to produce large coercive forces and can affect the demagnetization energy, Ed 
(see equation 1.12) 
 
    Ed = Kf sin2θ + (1/2)NiµoMs2                                         (1.12) 
 
where the shape anisotropy, Kf, varies depending on shape (Kf = µoMs2/4 for infinite wire 
but Kf = µoMs2/2 for infinite disks).24  For example, coercitivity increases by as much as 
four times when a spherical shape is deviated at aspect ratio of 0.4 in single domain Fe 
nanoparticles.  Contrary to shape anisotropy, magnetocrystalline anisotropy is intrinsic to 
the material and is independent to the shape of the particle. Crystalline anisotropy or 
magnetocrystalline anisotropy comes from spin-orbit coupling and determines the 
magnetic orientation of the material.24,25 Magnetocrystalline anisotropy is important 
because it determines whether a material correlates well to an application. Hard magnetic 
materials  have very high coercitivity (1-5T)26 to prevent reversal of  magnetization with 
magnetic field. Since the coercitivity is proportional to the anisotropy constant,18 a 
material with high magnetocrystalline anisotropy is attractive to applications utilizing 







 Many well known applications associated with magnetic nanoparticles are in 
ferrofluids. Basically, ferrofluids are magnetic fluids made up of small magnetic 
nanoparticles (mean diameter of 10nm) in a carrier liquid.1,13 Magnetic nanoparticles in 
ferrofluids are superparamagnetic and the magnetic force is proportional to the 
magnetization 27of the fluid. Therefore, even weak applied magnetic fields (order of a 
few mT) induce strong forces on ferrofluids. It is the combination of superparamagnetic 
behavior and normal liquid behavior that has led to their popularity.  
 There are thousands of applied and approved patents for applications of magnetic 
nanoparticles. The most recognized application is using ferrofluids in dampening devices. 
For example, the voice coils of loud speakers are often damaged through overheating as 
they oscillate between the poles of a circular magnet. Ferrofluids are filled in the gap of 
the permanent magnets of loud speakers, allowing the heat produced by the voice coil to 
be transmitted with an enhanced cooling rate (factor of 3).27 They have also been used in 
inertia dampeners such as stepper motors where the ferrofluid acts to provide torque 
opposing the stepper motor to prevent “ringing”.27 Another popular application of 
ferrofluids is in sealing technology. They are used as exclusion seals for computer disk 
drives.28 There, ferrofluids are used between the magnet and the highly permeable 
rotating shaft.27,28 They are held in place by the magnetic field and the concentrated 
magnetic flux increases the magnetic field thereby, increasing the pressure capacity. 
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Ferrofluids have also worked their way into optical applications such as optical switches 
and shutters though there is a lot of room for improvement. In the realm of biology and 
biomedicine, ferrofluids have also established a place for their application. A more 
elaborate discussion of the biomedical applications of ferrofluids can be found in section 
1.4.3.  
  
1.4.2 Data storage 
 
 On September 13th, 1956, IBM introduced the 305 RAMAC (Random Acess 
Method of Accounting and Control) computer that had a magnetic storage that replaced 
magnetic drums and Edison cylinders.29,30 The initiative was to maximize storage and 
minimize size. Compared to the standards of today, the magnetic storage capacity of 305 
RAMAC (4.4MB; areal density of 2 kbits/in2 )31 is miniscule. Since then, there has been a 
steady increase in storage capacity and decrease in physical size (Figure 1.8).29,30 
 By using CoPtCr granular media, an areal density in the order of ~40Gbit/in2 can 
be achieved. The goal for future growth is to get to an areal density of one or greater than 
one terabit/in2.32,33   To do so, the size of the magnetic nanoparticles used have to 
decrease. From the Stoner-Wohlfarth theory (see section 1.3.3), when the anisotropy 
energy decreases, a reversal of magnetization occurs. So when the particle size decreases, 
thereby decreasing the sample volume, thermal activation can overcome the anisotropy 
barrier causing random magnetization directions. This becomes problematic because it 
essentially means that data will be lost due to heat and vibration. To resolve the limitation 
established by superparmagnetism, IBM has developed an atiferromagnetically coupled  
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Figure 1.8 Diagram showing the steady increase in storage capacity and decrease in 
physical size hard disk drives after the commercialization of 305 RAMAC.29  
 
 
(AFC) magnetic media that delays the effects of superparamagnetism allowing for 
storage of 100Gbit/in2 and possibly more.34,35 Basically, in an AFC media, the magnetic 
layers are separated by a non-magnetic (ruthenium) layer that is approximately 3 atomic 
layers thin. This allows the magnetic layers to couple antiparallel to each other at 
significantly higher magnetic densities by increasing the signal to noise ratio in transition 
regions. Although this is an improvement, the ruthenium layer is deposited with 
sputtering techniques and nanoparticles are not used. By using magnetic nanoparticles, 
with larger magnetocrystalline anisotropy, it has been estimated that the storage capacity 
 20




1.4.3  Magnetic Resonance Imaging (MRI) Contrast Enhancement 
 
   Magnetic Resonance Imaging (MRI) is a powerful technique that images the 
human body based on the principles of nuclear magnetic resonance.36-38 It is the result of 
the difference in signal intensity that each tissue produces in response to a radio 
frequency pulse.39-41 First, a strong magnetic field is used to partially polarize the 
moments of protons. A radio frequency (RF) pulse is then applied to alter the steady 
state orientation of the protons. During the RF pulse, some of the RF photons are 
absorbed by the protons causing them to flip from parallel to being antiparallel (higher 
energy state) to the magnetic field. At the end of the pulse, the relaxation of the protons 
back to a lower energetic state produces small amounts of electromagnetic radiation and 
this signal is then registered with the detection coils and converted into an image. The 
factors that govern MRI are basically proton density and the magnetic relaxation times.  
 There are approximately 6.6 x 1019 protons in a cubic centimeter of water and in 
the absence of a strong magnetic field, the moments are randomly oriented. However, 
when a strong magnetic field is applied, the moments will try to align with the field 
direction and to do so they will have to overcome the thermal factor that facilitates their 
random orientation. Though the number of moments that align with the field is only 
slightly higher than those that are opposite in direction, there is an imbalance of about 2 
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x 1014 protons per cubic millimeter of water. In MRI, the imbalance of proton density is 
detected and mapped into an image. 
 The two relaxation time constants associated with MRI, longitudal (T1) and 
transverse (T2).40,41 The longitudal relaxation or spin-lattice relaxation time constant 
refers to the loss of energy to the “lattice” or the surrounding that results from the 
relaxation of proton nuclei to the lowest energy state. Basically, T1 defines the z-axis.40 
Since the magnetic potential energy is proportional to projection of this axis, a change in 
magnetization implies that the spin has interacted with its surroundings. Hence T1 can 
be considered to be a measure of the dipolar coupling of proton moments to their lattice.  
The transverse relaxation or spin-spin relaxation time constant refers to the effect in the 
relaxation process due to dephasing of the individual protons caused by a non-stationary 
magnetic field.40 Each proton will experience the external, stationary magnetic field (B0) 
along with magnetic field of neighboring protons. Since the angular frequency of a 
proton is proportional to the experienced magnetic field, the protons will precess at 
incoherent frequencies. When the protons precess at different frequencies it results in a 
net decrease of magnetic moment in the xy-plane with time. The time period from 
maximum value to zero is characterized by T2.  
 The quality of the magnetic resonance image can be enhanced by contrast agents. 
The principle behind contrast agents is how they alter the T1 and T2 constants. By 
decreasing T1, the signal is essentially amplified. By decreasing T2, broader lines are 
generated but at decreased signal amplitudes. Most contrast agents are paramagnetic 
species with unpaired electrons that can affect T1 and T2. Contrast agents can be simple 
molecular oxygen, stable radicals or metal ions. Since radicals may cause damage to 
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tissues in general and that the paramagnetic effect of oxygen is weak, metal ions are the 
best options. The first proposed contrast enhancement agent was Chromium-EDTA but 
their long term stability prevented their use in clinical applications.42 Although 
gadolinium – diethylenetriaminepentaacetic acid (Gd-DPTA)43 has been approved by 
the US FDA and is currently marketed as Magnetvist, another class of contrast agents 
has demonstrated equivalent if not better enhancement to MR images. This other class 
of contrast enhancement agents belongs to the superparamagnetic family. Since 
superparamagnetic species do not have a hysteresis above their blocking temperature 
and behave like paramagnetic nanoparticles above their blocking temperature, they are 
attractive enhancement agents that do not leave remenance magnetization when the 
magnetic field is terminated.40 In addition, their relaxation time is very high compared 
to paramagnetic species like Gd-DTPA. In fact, the most commonly used contrast 
enhancement agents now are superparamagnetic iron oxide nanoparticles. For  example, 
Feridex I. V, marketed by advanced Magnetics Inc., is used to image liver or gallbladder 
disorders. Another marketed iron oxide contrast agent is Resovit®, used in imaging and 
detection of tumors.  
  
1.4.4 Magnetic Hyperthermia 
 
   Hyperthermia is basically a heat treatment that induces necrosis or promotes 
adoptosis.44 It can be considered a co-treatment, i.e. treatment in conjunction with other 
therapy or it can be considered a stand alone treatment. There are several modes of 
hyperthermia, radiofrequency capacitance hyperthermia (RFCH), microwave antennae 
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hyperthermia (MH), whole body hyperthermia (WBH), isolated hepatic perfusion 
hyperthermia (IHPH), and magnetic mediated hyperthermia (MMH).45 Generally, the 
process involves heating tissues or cells above the therapeutic threshold temperature 
(42-46°C) for 30 minutes. However, all but MMH can risk necrosis to healthy tissues 
due to non-specific targeting abilities. Other techniques such as radiofrequency probe 
(RFP), microwave probe (MP), interstitial laser photocoagulation (ILP), and direct 
injection of hot water to tumors are specific targeting methods but require multiple 
repositioning due to limited heat diffusion.45 The most promising hyperthermia 
treatment is with magnetic mediated hyperthermia.  
 Magnetic mediated hyperthermia was first addressed by Gilchrist, et al. in 1957 to 
treat lymphatic metastases of large bowel cancers.46 The concept encompasses using a 
magnetic field to localize γ-Fe2O3 ferromagnetic nanoparticles within the target region 
and maintaining the field for a specified duration. They found that within 3 minutes at 
200-240 Oe field strength, the lymph node tissue heated up to 14°C. Two years later, 
they demonstrated that by increasing the field strength to 470 Oe, total necrosis of the 
lymph node was accomplished. Since then, numerous studies have been published using 
different nanoparticles for MMH as well as different methods of delivery. Currently, 
most of the magnetic nanoparticles used for hyperthermia are superparamagnetic since 
they can generate more heat at lower magnetic fields than ferromagnetic 
nanoparticles.40,45 The heating mechanism of ferromagnetic nanoparticles and 




1.4.5 Magnetic Separation 
 
   In biomedicinal studies, evaluating biological entities outside of their native 
environment can be important. Most of the time this is accomplished through multiple 
extractions and centrifugation processes. In the process, the concentration of targeted 
sample may be reduced from its actual concentration. A more efficient method is to use 
magnetic separation. Using the abundant linker groups commercially available, 
magnetic nanoparticles can be coupled to effectors or macromolecules. The resulting 
magnetic nanoparticle – macromolecule complex can then be separated magnetically or 
used to recognize counterparts then separated magnetically. For example, Pel Freez had 
developed a dextran-coated magnetic nanoparticle (magnetite) conjugated to a 
tetrameric antibody that recognizes dextran at one end and surface antigens on the cell at 
the other terminus.48 With a weak magnetic field, cells recognized by this dextran 
coated magnetite – tetrameric antibody complex can be isolated from a mixture of cells 
without the complimentary antigen.  Additionally, magnetic separation has been adapted 
for erythrocyte separation and quantification. In normal red blood cells, the organization 
of phosphatidylserine is oriented in such a way that it faces the cytoplasm. In damaged 
red blood cells, this organization is random and the distribution of phosphatidylserine is 
asymmetric.49 An intracellular protein, Annexin V, has the capability to specifically 
bind to phosphatidylserine in the presence of Ca2+. Hence, when coupled to magnetic 
nanoparticles, it provides a way to separate the damaged red blood cells from the normal 
red blood cells for further quantification. This is an important aspect since the number 
of damaged red blood cells has correlations to erythrocyte evolution in patients with 
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malaria and Alzheimer’s disease.50 Quantification of damaged red blood cells is also a 
marker for the quality of stored human blood in blood banks. The coupling of Annexin 
V to magnetic nanoparticles has demonstrated such promising applications that it has 
been patented and is being evaluated for market manufacture.51 However, there are 
many more applications that can be associated with magnetic separation of 
macromolecules. For example, coupling magnetic nanoparticles with effectors that 
recognize unusual membrane modifications may provide information such as apoptosis 
and membrane organization that are all important to cancer research.52 
 
1.4.6 Drug Delivery 
 
   When surgical removal of malignant tumors is not an option, chemotherapy and 
radiation are generally the choice of treatment for many patients.  However, many of the 
side effects associated with chemotherapy and high dosage therapeutic drugs have 
introduced more complicated matters. Radiation therapy is not target specific therefore, 
destroying healthy cells along with cancerous cells. When cancer has spread throughout 
the body, other treatments such as chemotherapy are used.  The main function of most 
chemotherapeutic reagents is to target and destroy cells that proliferate at an abnormally 
high frequency. Malignant cells proliferate at high frequency as well as hair follicle cells. 
With the non-specificity of chemotherapy, many patients will lose their hair on their 
head, lose their eyebrow, and even eye lashes. Another example is with patients that 
suffer from chronic inflammation. Many times, the treatment involves high dosages of 
therapeutic reagents. As the therapeutic reagent circulates through the body, the efficacy 
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of the drug is dramatically reduced. The side effects and reduced effectiveness of 
therapeutic reagents is attributed to the non-specific recognition of the therapeutic 
reagent.  
 To reduce side effects and maximize drug effectiveness, scientists have proposed 
the use of magnetic nanoparticles as carriers for therapeutic reagents. For example, 
Widder, et al. demonstrated that by administering magnetic carriers – doxorubicin 
(cytotoxic drug) to sarcoma tumors in rat tails, total remission occurred 53non-
magnetically did not show remission.54 This concept has also been adapted by private 
companies such as FeRx, who have entered clinical phase II and III studies. Pending 
funding, this type of treatment may be the alternative to radiation and traditional 
chemotherapy to humans. The point is to be able to guide or localize the therapeutic 
reagent once in the system with a magnetic field. This prevents or reduces the amount of 
therapeutic reagent lost during circulation and localizes the treatment to a specified 
region. 
 
1.5 Outlook of Magnetic Nanoparticles in Biology  
 
 The concept of using magnetic manipulation system for minimal invasive medical 
and biologically related applications has been around since the 1950s55-59 and will 
continue to progress. There are many underlying issues that must be resolved and 
optimized. For example, magnetic carriers carrying therapeutic drugs are often 
administered intravenously or intra-arterially. Hence, factors such as the blood flow rate, 
magnetic nanoparticle concentration, circulation time, and tissue depth will all play a 
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major role in the development of future magnetic carriers. Another important factor is 
aggregation. It is extremely important that the intrinsic attraction of the magnetic 
nanoparticles do not form aggregates or the possibility of clotting may occur. Although 
there are mathematical models of hydrodynamics involved60 as well as models for safe 
target specific treatment61, none addresses all of the issues. Hence, there is ample room 
for improvement.  
 In MRI, novel magnetic nanoparticles with characteristics that will enhance the T1 
to T2 ratio can further enhance the contrast during imaging. In drug delivery, different 
approaches of coupling therapeutic reagents to magnetic nanoparticles as well as the 
development of systems that will allow these conjugates to be safely administered in 
vivo will need to be optimized. With the expanding variety of magnetic nanoparticles 
and the versatility of its intrinsic properties with change in composition and size, 
magnetic nanoparticles can be tailored for specific functions and play a major role in 
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2.1 Spinel Ferrites 
 
 The term spinel is named after the mineral, MgAl2O4. It has a general chemical 
formula of AIIB2III O4, where A is a divalent cation (M2+) and B is a trivalent cation (M3+) 
(Figure 2.1).1 There are two categories of spinel phases, normal and inverse spinels. In 
normal spinels, the A sites are tetrahedrally coordinated and the B sites are octahedrally 
coordinated. In reverse spinels, half of the tetrahedral sites are occupied by BII and half 
by BIII. All of the octahedral sites of an inverse spinel are occupied by AIII. When M2+ 
and M3+ cations both occupy A and B sites, the system is a mixed spinel. The lattice 
characteristics of a spinel include a FCC site for the oxygen atoms and two cationic sites 
occupying the tetrahedral and octahedral interstices.1-4 In a spinel, there are 64 tetrahedral 
sites, 32 octahedral sites, and 32 oxygen sites in a unit cell. Due to their exchange 
coupling, spinel ferrites are ferrimagnetically aligned where all of the moments of A sites 
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are aligned parallel with respect to one another (likewise moment alignment for B sites 
with respect to one another) while moments of A and B sites are antiparallel to each other. 
 The magnetic properties of spinel ferrites are greatly influenced by composition 
and cation distribution. Variation of the cation distribution between the cationic sites 
leads to different magnetic properties even if the composition of the spinel is the same. 
For example, a blocking temperature change of as much as 50°C has been observed in 
MnFe2O4 nanoparticles with a 29% inversion in distribution of cations.2 When comparing 
similar systems with different composition such as CoFe2O4 and MgFe2O4, there is 
always a large difference in the blocking temperature (~150K) that can be attributed to 
the spin-orbital coupling of the cations as well as superparamagnetic properties. While 
there are three unpaired d electrons present in Co2+, all of the electrons are paired in Mg2+. 
So while Co2+ cations have a large spin-orbital coupling, the paired electrons of Mg2+ 
does not provide any contribution to the electron spin. Magnetocrystalline anisotropy 
arises from spin – orbit coupling.5-7 If we relate the spin – orbit coupling factor to the 
Stoner – Wohlfarth theory, there would be an increased energy barrier. As a result, a 
larger blocking temperature is required to overcome this large anisotropy energy barrier.  
Hence, the influence of cation distribution and chemical composition can greatly 
influence the tunability of the magnetic properties of spinel ferrites.  
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Figure 2.1  Partial unit cell structure of a typical spinel ferrite.4 
 
 
2.2 Synthesis Methods of Magnetic Nanoparticles 
 
2.2.1 Ball Milling 
 
 Ball milling is a mechanical alloying method used to manufacture oxide 
dispersion that are used to strengthen alloys.8 The process involves vigorous mixing of 
the powder starting material and milling balls in a vial for several hours. The vigorous 
shaking action permits the starting material caught between milling balls to be crushed 
during collision of the balls. The repetitive collision generates enough energy to produce 
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non-equilibrated nanostructures, usually in an amorphous or quasi-crystalline state. 
Recently, this technique has been employed to synthesize magnetic spinel ferrites such as 
ZnFe2O4.9 Although this is a method that can produce large quantities of nanomaterials 
with cost efficiency, it lacks the ability to produce monodispersed and crystalline 
magnetic nanoparticles. 10-13 
 
2.2.2 Sonochemical Method 
 
 Sonochemistry uses ultrasound to assist or enhance a chemical reaction. 
Nanoparticles can be produced using sonochemical methods that involve the process of 
cavitation.14,15 Cavitation is best described as the formation, growth, and collapse of 
bubbles.14,15 When acoustic waves are introduced in liquids, the decompression cycle of 
the acoustic waves can generate bubbles. During the decompression or expansion cycle, 
negative pressure exerted on the liquid pulls molecules apart and eventually exceeds the 
local tensile strength of the liquid creating a cavity or bubble. Bubbles then grow in the 
decompression phase by absorbing energy from the acoustic radiation. Once bubbles 
have grown to a critical size (varies with different liquid), they can no longer efficiently 
absorb energy and this allows the surrounding liquid to enter the bubble(compression) 
causing it to implode.  During the implosion or collapse of these bubbles, a short-lived 
(µs) hot spot in the range of 5000°C and several hundred atmospheres can be 
generated.14,15 The size of bubbles generated and the cavitation time scale can be best 
described through Figure 2.2. Through sonochemical methods, ferrites such as NiFe2O416 
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and Fe3O417 have been produced. In most cases, the end product is amorphous and highly 





Figure 2.2  Cavitation process.15 
 
2.2.3 Sol-gel Method 
 
 A sol can be defined as a colloid suspended in a liquid medium whereas a gel is a 
sol network interconnected to form a rigid framework. Since the colloids that make up 
the sol are between 1-100nm the gel they make up can have pores from the nanometer to 
micrometer dimension.19,20 In addition to being a controllable and practical method to 
make glasses and ceramics, the mild condition of a sol-gel synthesis allows for the 
preparation of other unique materials such as films, fibers, coatings, and of particular 
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interest, nanoparticles (Figure 2.3).21 For example, terbium doped cobalt spinel ferrite, 
CoFe2-xTbxO4, has been synthesized through a sol-gel process.22 









 Generally, the sol-gel process is classified as either inorganic based or alkoxide 
based. The synthesis of materials through a sol-gel process can be described in the 
following generalized steps. First, a sol is produced by reacting precursors (e.g. Si(OR)4), 
solvent, and a catalyst. Hydrolysis in an aqueous solution followed by condensation 




















time, the sol particles grow into macroparticles and through condensation they form an 
elastic gel. Through polycondensation, the gel is then aged so that a more rigid 
framework is developed.23-25 The gel is then dried by evaporation or through a 
supercritical drying process.   
 Although the sol-gel synthetic method can generate uniform nanoparticles, the 
difference in hydrolysis rates of precursors may result in chemical inhomogeneity and 
can lead to higher crystalline temperature and undesirable crystalline phases.21 
Depending on the drying method used, cracking of the gel and shrinking of the pores may 




 The co-precipitation process of synthesizing nanoparticles can yield nanoparticles 
with a wide spectrum of sizes ranging from 5-180nm.4,26 The process is relatively simple. 
Inorganic salts are mixed in an aqueous environment then precipitated out with hydroxide 
base. The resulting precipitate is then digested, filtered, then dried in a furnace. Using this 
method, magnetic nanoparticles such as magnetite,27,28 manganese ferrite2,29, and 
magnesium ferrites30,31 have been produced. Parameters such as the ratio of starting 
materials and the oxidation state of starting materials can make a difference in the size of 
the resulting nanoparticle. For example, using ferric (Fe3+) salts with other divalent ions 
can generate particles in the range of 5-25nm.29 On the otherhand, through an Ostwald 
ripening process using ferrous salts with an oxidizing reagent, larger magnetic 
nanoparticles (up to 180nm) can be made.29  
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 Although co-precipitation is a simple process, it has disadvantages. When 
compared to other synthetic methods such as microemulsion methods (see section 2.2.6), 
the resulting nanoparticle is strongly aggregated.29,32 The aggregated particles limit 
further application that will require surface modification. Another disadvantage is the 
relatively non-uniform and metastable size distribution (especially sizes below 20nm)33 
as well as a mix of magnetic states. Studies have shown magnetite synthesized from co-
precipitation methods usually have both clusters that are superparamagnetic and 
ferromagnetic simultaneously.32 Following the digestion process, the method calls for 





 The magnetic properties of magnetic nanoparticles can be dramatically affected 
by the distribution of cations in the tetrahedral and octahedral sites. Thus far, all of the 
synthetic methods discussed produce amorphous magnetic nanoparticles and will require 
further heat treatment. Zhang, et al. demonstrated that the size of nanoparticles as well as 
the cation distribution is affected by high annealing temperatures.2 Hence, any method 
that requires heat treatment does not offer size control or cation distribution control. A 
better method to synthesize nanoparticles is through microemulstion. By definition, a 
microemulsion is a dispersion of one liquid in another stabilized by an interfacial film of 
surfactants.34,35 The dispersion can be classified as water-in-oil (reverse phase) or oil-in-
water (normal phase).  In both types of microemulsion (see figure 2.4a and 2.4b), the 
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amount of surfactant used is above their critical micelle concentration (cmc).  The 
aggregation of surfactant forms 10-100nm micelles. Both types of dispersions can 




                
(a) (b) 




2.2.5.1 Reverse Micelle Method 
 
 Reverse micelles are water-in-oil droplets stabilized by surfactant molecules. The 
polar termni points in towards the hydrophilic interior of the micelle and the oily chains 
point out (see Figure 2.4a). These micelles are essentially nanoreactors. The reverse 
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micelle process has been used to make semiconductors with controllable size and high 
homogeneity as well as magnetic nanoparticles such as Fe3O4 and MFe2O4 ( M = Co, Mg, 
Mn, Cu).3,4,35,37-43 This method also allows for doped nanoparticles to form products such 
as CoCrFeO4.44 Generally, the process involves mixing divalent salts in a surfactant 
solution. Toluene or another organic solvent is then slowly added and reverse micelles 
are allowed to form. Upon complete formation, base is added to the solution to precipitate 
the particles. The volume is then reduced by refluxing and the particles are isolated 
through centrifugation. The reverse micelle method in general can produce controllable 
sizes and homogeneous nanoparticles.  
 Size control in synthesis of magnetic nanoparticles is an important parameter. The 
most reported method of varying the size of magnetic nanoparticles is by adjusting the 
surfactant to water ratio or water to organic solvent ratio to change the droplet size. For 
example, it has been shown that by adjusting the water to surfactant ratio, different sized 
MnFe2O4 can be made. By correlating the droplet size using the general formula of  
 
     D(nm) = 0.3w                                              (2.1) 
 
where w = [H2O]/ [AOT], Carpenter et al. were able to make 10nm MnFe2O4 when w = 
10 and 5nm MnFe2O4 when w = 0.01.41,43 While equation 2.1 address the Na(AOT)-
water-isooctane system, similar principle is applied for other systems. For an example, by 
using  
 
       (93-x)/7/x                 (2.2) 
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where x corresponds to the cyclohexane/Brij/aqueous iron solution, Lopez-Perez were 
able to make Fe3O4 nanoparticles ranging from 1.9nm-7.3nm.42 Though many ferrites can 
be accomplished through normal micelle methods as well, a successful normal micelle 
synthesis of CuFe2O4 and MnFe2O4 has never been reported4 but can be synthesized 
through reverse micelle methods.39 
  
2.2.5.2 Normal Micelle Method 
 
 A general structure of a normal micelle can be seen in Figure2.4b. The 
hydrophobic organic (oily) chain is directed to the core of the micelle and the polar 
terminus is oriented towards the outside or the perimeter of the micelle. Normal micelle 
have been successfully applied to prepare many spinel ferrite systems such as iron oxides, 
cobalt ferrites, and transition metal or lanthanide doped cobalt ferrites.39,42,45-48 Generally, 
metal cations are mixed with a surfactant, typically sodium dodecylsulfate (SDS; 
CH3(CH2)10CH2OSO3-Na+). The metal cations will associate with the polar head groups 
and above the critical micelle concentration, the surfactant molecules will aggregate to 
form micelles “confining” the metal cations in solution.4 The critical micelle 
concentration for normal micelle synthesis is generally very low relative to co-
precipitation methods. Typically it is in the 1.5mM range at room temperature. 
Nanoparticles are precipitated out with base then isolated through centrifugation then air 
dried. 
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 Like the reverse micelle method, the normal micelle method offers control in the 
size of the nanoparticle. In order to vary the size of the particle, adjustments to the 
surfactant concentration, metal salt concentration, base concentration, and reaction 
temperature can be made. Rondinone, et al. demonstrated through chemometric 
modeling , the parameters that will correlate to a size change in CoFe2O4 nanoparticles.48 
A cross sectional three-dimension plot of the effects of metal salt concentration and base 
(methylamine) concentration at constant reaction temperature generated a saddle shaped 
graph (see Figure 2.5) implying a strong interaction between metal ions and base.48,49 
When the plot of the effects of metal salt concentration with varying temperature using a 
constant concentration of base was generated (Figure 2.6), the curve indicated that the 
parameters are independent of one another. Therefore, if the reaction temperature is 
increased at varying concentrations of metal salts, the size of the nanoparticles is 
increased. Likewise, when the salt concentration is increased at various reaction 
temperatures, the size of the nanoparticles also increases.  Using the factors resolved by 
Rondinone, et al.48, the magnetic nanoparticles synthesized in this thesis were all 











Figure 2.5 Three-dimensional cross section plot illustrating the effects of metal salt 





Figure 2.6 Three-dimensional cross section plot illustrating the effects of metal salt 




2.2.6 Seed Mediated Thermal Decomposition Method 
 
 The drive to attain better control of size distribution and shape of magnetic 
nanoparticles is an ongoing process. Thus far, synthetic methods such as sol-gel, co-
precipitation, and microemulsions have demonstrated their ability to produce nanosized 
particles with some control. However, none of the methods can provide shape control. 
Recently, Zhang and Song50 as well as Sun et al.33 developed, in parallel and 
independently, methods to produce magnetic nanoparticles with controllable size and 
shape. The basic strategy is to synthesize nanoparticles using coordinating metal 
precursors in a nonhydrolytic process then using the resulting magnetic nanoparticle as a 
seed for further growth. By adjusting the concentration of the precursor monodispersed 
nanocrystals of 3-9nm can be produced. Depending on the size of the seed nanoparticle, 
monodispersed nanocrystals up to 20nm have been synthesized.33 Since the seed 
mediated growth takes place above the thermal decomposition temperature, the rate at 
which the growth occurs is the key factor to the resulting shape of the nanoparticle. For 
example, at a slow heating rate, a cubic shaped CoFe2O4 is produced versus a spherical 
CoFe2O4 at higher heating rates.  The change in shapes has been attributed to the heating 
rate, availability of metal cations, and selective directional growth.50  
 The applications of monodispersed nanocrystals with controlled shape have 
strong grounds. It has been implied that MFe2O4 (M = Co, Li, Ni, Zn, Fe) can potentially 
be utilized in high-performance electromagnetic devices, and spintronic devices.33 In 
addition, they can improve on many of the bio-applications currently available. To 
address the bio-applications, the nanocrystals must be hydrophyllic or through surface 
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modifications be made hydrophilic. It has been shown that through solvent extraction, 
hydrophobic nanocrystals, Fe3O4, can be made hydrophilic.33 With the current 
development and future progress, bio-applications with magnetic nanoparticles with 
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INSTRUMENTATION AND RELATED TECHNIQUES 
 
 
3.1 Magnetic and Physical Characterization Instrumentation 
 
3.1.1 Powder X-Ray Diffraction 
 
 X-rays, discovered by W. C. Röentegen in 1895, have led to the development of 
major characterization instrumentation utilizing the principles of the X-ray.1-5 Three well 
known categories of instruments are X-ray fluorescence spectrometry, X-ray radiography, 
and X-ray crystallography. In X-ray fluorescence spectrometry, secondary radiation from 
materials excited by an X-ray source reveals the amount of a particular element in the 
material.4 In X-ray radiography, the relationship between the density of the material and 
its X-ray absorptivity is revealed.4,5 The most useful technique to identify the structure 
and crystallinity of material is through X-ray crystallography.1,2,4,5 Powder X-ray 
diffraction (XRD) belongs to the family of X-ray crystallography and although it is an 
established technique for bulk materials, it is now commonly used to nondestructively 
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characterize nanostructures such as magnetic nanoparticles. The XRD used throughout 
this thesis for the characterization of magnetic nanoparticles is a Bruker D8 Advance X-
ray diffractomer with CuKα radiation.  
 To generate X-rays, a current is passed through a conducting wire or filament 
(tungsten filament) and due to the resistance of the filament, it will heat up. The heat 
generated is sufficient enough to eject electrons. A potential difference between the 
anode and the cathode will accelerate the free electrons towards the cathode, a copper 
target.  If there is sufficient energy, the bombarding of electrons onto the anode may 
knock an outer electron of the anode out of its orbit generating an x-ray radiation.  
 When X-ray radiation strikes a powder sample, the layers of crystals of the 
sample act like weak mirrors that “reflect” the x-ray beams. The angle of “reflectance” 
equals to the angle of incidence for each row of atoms (Figure 3.1.). Interference then 
occurs between the beams reflecting off different rows of atoms in a crystal.1,3,4 For 
constructive interference, the order of interference must be an integer. This results in 
Bragg’s law given in equation 3.1. 
 
 
                                               nλ = 2d sinθ  (n = 1, 2, 3, ….)                                          (3.1) 
 
 
where n is the order of interference, λ is the wavelength of the incident x-ray beam, d is 
the distance between atomic layers in the crystal, and θ is the angle of incidence.  
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 Data collected from XRD can be used to gather information about phase 
identification, phase purity, and crystallite size.1,3,4 Experimental diffraction patterns can 
be compared to those in the JCPDS (Joint Committee on Powder Diffraction Standard) 
database for phase identification. The peak broadening of the experimental diffraction 
peak can also give us information of the diameter of the particle through the Scherrer 
formula (equation 3.2) 
 
                                                         B = 0.89λ / t cosθ                                                    (3.2)   
 
where B is the broadening of the XRD peak at full width half maximum, λ is the 
wavelength of the incident x-ray beam, θ is the diffraction angle, and t is the diameter of 





Figure 3.1  Interference between x-ray beams scattering rows of atoms in a crystal. Figure 








3.1.2 SQUID Magnetometry 
 
 SQUID (Superconducting QUantum Interference Device) magnetometry is 
governed by two principles, the Josephson’s effect and the quantization of magnetic flux 
of a superconducting ring.4, 6-10 It is one of the most sensitive instruments available for 
magnetic measurements yet it can also operate at 10 tesla.11  The nominal resolution of 
SQUID is about 1fT and it has a threshold of 10-15 – 10-16T. SQUID magnetometers can 
measure the magnetic flux of one flux quantum (magnetic flux of Earth’s magnetic field 
through a 7 micron human red blood cell) and has been used to measure the magnetic 
field of the brain of a mouse to test whether the magnetic field in their brain is enough to 
assist their internal compass.8 Table 3.1 puts the sensitivity of SQUIDs in perspective, 
comparing earth’s magnetic field with magnetic fields of the body. The sensitivity of the 
SQUID is attributed to the Josephson junction that allows the detection of changes in the 
magnetic field associated with one flux. One flux is quantified as: 
 
                                           Φ0 = 2h/2e ≅ 2.0678 x 10-15 T⋅m2                                         (3.3) 
 
In a Josephson junction (Figure 3.2), two superconductors are separated by thin insulating 
layers, thin enough to allow Cooper pairs (bosons or bound electrons formed by electron-
photon interaction) propagating through the superconductor to tunnel through the 




Table 3.1. A comparison between the magnetic field of Earth, human body, and the 


















SQUID coil induces an electrical current. The change in current in response to the 
magnetic flux of the sample generates a phase difference across the Josepheson junction. 
Since the current is quantized, the interference between the two junctions ultimately 
changes the current passing through the superconducting circuits. The changes are 
detectable and can be correlated to the magnetic flux. 
 Magnetic Field (T) 
Neutron stars 108 
Strongest destructive pulsed 
magnet at NHMFL – Los Alomos  
850 
High energy particle accelerators 10 
Magnetic Resonance Imaging 0.5-5 
One horsepower electric motor 0.1-0.2 
Refrigerator Magnets 10-4 – 10-3 
Earth’s Magnetic Field 5.0 x 10-5  
Human heart’s magnetic field 10-9 – 10-8 
Intergalactic and Interstellar 
magnetic field 
10-11 
Human brain’s magnetic field  10-13 
Threshold of SQUID 10-14  
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 There are two types of magnetic measurements that can be made by the SQUID. 
The first type of measurement is field dependent and temperature independent, M(H). 
The second type of measurement is temperature dependent and field independent, M(T). 
Both types of measurements can be performed through a zero field cooled (ZFC) or field 
cooled (FC) method. In the ZFC method, a sample at room temperature is cooled to a 
designated temperature in the absence of a magnetic field.  As a magnetic field is applied, 
the magnetization is recorded as the temperature is steadily ramped. In the FC method, 
like the name implies, the sample is cooled from room temperature in the presence of a 
magnetic field.  In this thesis, measurements are taken using a Quantum Design MPMS-






dependent measurements were conducted from 5-700 K with a constant magnetic field of 
100 G. Field dependent measurements were conducted at ±5 T with a constant 
temperature of 5K.  
  
3.1.3 Transmission Electron Microscope (TEM)  
 
 Transmission Electron Microscopy (TEM) operates on principles similar to that of 
the optical microscope.12,13 The sample illumination source in a TEM is a beam of 
electrons. This beam of electrons travels through a column under vacuum and is then 
focused into a very narrow beam with electromagnetic lenses. Some electrons will scatter 
and those that do not scatter strike a fluorescent screen giving rise to a contrast image 
based on sample density.  Since the limit of resolution is in the order of a few angstroms, 
it is a very useful and powerful tool for nanoparticle characterization. Low resolution 
TEM can generally provide information regarding the size and overall shape of the 
sample and is routinely used to elucidate such information. The TEM used in this thesis 
was a JEOL 100C at 100 kV. All samples were dispersed in either water or ethanol onto 
holey carbon grids. 
 
3.1.4 Inductively-Coupled Plasma Optical Emission Spectrometry (ICP-OES)  
 
 Elemental analysis has always been important in Analytical chemistry as well as 
environmental sciences. In the 1940s, arc and high-voltage spark spectrometry were 
commonly used for elemental analysis.14,15 As time progressed, flame emission 
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spectrometry was introduced but was shadowed by atomic absorption spectrometry. It 
was not until the 1970s when inductively coupled plasma optical emission spectrometry 
was introduced.15 Since its introduction, rapid progress on the development and 
commercialization of ICP-OES has established it a standard technique for mulit-element 
analysis. This technique is now used more than most other analysis techniques for trace 
metal analysis.15-17  
 Inductively coupled plasma optical emission spectrometry (ICP-OES) is 
sometimes referred to as inductively coupled plasma atomic emission spectrometry (ICP-
AES).15  Since most particles in the plasma are ions and since AES can also represent 
Auger Electron Spectroscopy, the proper terminology is ICP-OES. However, it has been 
recommended by ISO12235 that “O” be dropped and the technique to be termed ICP-
ES.15 In literature, ICP-AES, ICP-OES, and ICP-ES are used interchangeably. In this 
thesis, the technique will be referred to as inductively coupled plasma optical emission 
spectrometry (ICP-OES).  
 A typical ICP-OES instrument will be comprised of a sample introduction system, 






Figure 3.3 Schematic representation of an Inductively Coupled Plasma Spectrometer.16 
Basic components include sample introduction system, torch, generator, optics, 




is introduced into the ICP through an introduction system to the torch where the plasma, 
at several thousand Kelvin (5000-1000 K), breaks down the sample into its elemental 
form.14-17 Therefore, the chemical bonds or the chemical composition of the sample do 
not influence the analytical result. The hot plasma produces enough energy to excite 
atoms and ions of the element.15,17 This is why ICP is sometimes thought of as a hot 
flame emission spectrometry technique. The emission of electromagnetic radiation from 
these atoms and ions as they decay to ground state are then resolved through optics and 
quantified and identified with a detector.15,17 Data collected is then compared to one 
generated by a standard series and the concentration of each element in the analysis is 
then extrapolated. The ICP-OES system used throughout the compiled studies of this 
thesis is a Perkin Elmer Optima 3000 ICP-OES. 
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3.2 Biologically Related Instrumentation and Techniques 
 
3.2.1 Laser Scanning Confocal Microscopy (LSCM)  
 
 In conventional wide field or brightfield microscopy, a specimen is illuminated 
with light from either a mercury or xenon source.18 The image is captured directly as 
either photographs or displayed on an image capturing device.18,19 Though simple and 
convenient to use, wide field microscopes becomes problematic with fluorescent and/or 
thick samples (>2 µm).18,19  When background fluorescence is emitted by the specimen, 
the luminescence may interfere with the focused specimen. On the contrary, with 
confocal microscopy, specimens are illuminated by beam(s) of laser(s) scanning across 
the surface.18,19 This enables the region scanned by the laser(s) to be in focus and 





Figure 3.4 Illumination difference between conventional wide field microscopes and laser 
scanning confocal microscopes. 
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 The creation of confocal microscope is accredited to Marvin Minsky whom 
invented the concept in 1955 and patented it in 1957.18-20  The evolution of this 
instrument was to capture biological occurrences in vivo. Minsky placed an actual 
pinhole in front of the light source. The light was then focused by an objective onto the 
specimen at the point of interest. As light is reflected and transmitted, the transmitted 
light is focused by a second objective that has the same focus (defined as confocal). Once 
again light is either reflected or transmitted. The light that is transmitted through the 
second focal point strikes a photomultiplier which amplifies the signal to be processed.  
A schematic of the basic components of and light path in a confocal microscope can be 






Figure 3.5 Schematic representations of the components of a typical confocal microscope. 
A laser is used as a light and excitation source. The beam of laser is focused onto the 
sample. Light signal hits the low noise photomultiplier tube and is then amplified, 






















3.2.2 Dark Field Microscopy 
 
 Generally, dark field microscopy is used to visualize transparent materials or 
materials that have a refractive index close to their environment making them hard to 
visualize under bright field microscopy. Contrary to bright field microscopy, where the 
central light passes through and around the specimen of interest (Figure3.4), dark field 
microscopy, only permits oblique or indirect rays at every azimuth to strike the 
specimen.21,22 The components of a dark field microscope are very similar to that of a 
bright field microscope. The difference is the use of high numerical aperture dark field 
condenser/ objective pair (Figure 3.7). The light stop of the condenser prevents central 
rays from striking the specimen.   The striked rays are then scattered in different manners 
by optical discontinuities.21,22 For example, different organelles of the cell will scatter at 
different wavelengths. At regions where no specimen is present, the field of view will be 
dark. Only the scattered regions will show up as illuminated structures. In this thesis an 
Olympus IX70 inverted microscope housed with a 100X dark field condenser / objective 













3.2.3 Flow Cytometer 
 
 Flow cytometry is essentially an extension of fluorescence microscopy. It is 
defined as the detection of cells as they flow rapidly through an orifice in a single file.23-
25  The development of flow cytometry began in 1934 when Andrew Moldavan suggested 
taking a static microscopy technique and implementing it towards a flowing system.23 
This idea was advanced by Wallace Coulter as he developed a Coulter technique that 
allowed the quantification of cells in a flowing liquid stream. Further advancements by 
Louis Kamentsky and Myron Melamed in 1967 as well as contributions from other 
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research progress by Mack Fulwyler, P.J . Crosland-Taylor, and Marvin Van Dilla, 
facilitated the development of the flow cytometer that is commonly used in hospital labs 
and research laboratories today.23 What started as a technique to count red blood cells is 
now applicable to differentiate various types of cells.  
 The components common to most flow cytometers include a light source, stage, 
lens, filters, and a detector. A general schematic of the components can be seen in figure 
3.8. The light source in a flow cytometer is typically a laser or multiple lasers. A laser 
produces an intense beam of monochromatic light that is usually very important for the 
excitation of specific dyes. On the contrary to static microscopy techniques, the stage on 
a microscope is basically a flow cell where a flowing stream of cells are scanned/counted 
as they pass by the analysis point. Normally, the flow cells will have a nozzle size 
between 50-250 µm; a non-sorting flow cytometer nozzle size tolerates 50-100 µm and 
sorting flow cytometers have nozzle sizes from 150-250 µm. As the laser beam projects, 
it is aligned and focused with a lens or a series of lenses. Likewise, the light that emerges 
from the intersection of the sample stream and analysis point is collected with lenses that 
surround the analysis point. The light is then focused onto the detector, usually a 
photodiode or photomultiplier tube, where the light signals is converted into an electrical 
signal. Depending on the position of the detector, either forward scattering signal (FSC) 
is collected, side scattered signal (SSC) is collected, or both. When the detector sits in the 
path of the illuminating beam then the light that emerges from the analysis point, bending 
around the cell, will be forward scattering. This type of data is useful if the cross-
sectional area, size, or volume of the cell is of interest. Light that is emerges pass the 
analysis point at a right angle are fluorescent signals. Through color filters, specific 
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wavelengths can be selected to be detected by the photodectors. Most current models, 





Figure 3.8 Basic components of a flow cytometer include laser(s) as an illuminating 
source, flow cell to house the capillary that cells flow through in a single file, lenses to 
focus laser(s) and to focus the signal, filters to select specific wavelength(s) for detection, 





















3.2.4. Cell Culture Techniques 
 
3.2.4.1 Introduction to Cell Culture 
 
 Tissues extracted from an animal are enzymatically digested and then dispersed 
into cell culture.25 Daughter cultures can then be formed by seeding from the original 
culture. This is the process of passaging. Through multiple daughter cultures, a cell line is 
developed. A cell line can be classified as either primary, secondary, or immortal.25 
Primary cells are taken directly from tissues of a donor organism and are not continuous 
cell lines. They are only capable of a couple of cycles of cell division but can sustain 
viability for a long time given proper conditions. Primary cell lines are good 
representation of in vivo systems.25 Secondary cells are also explanted directly from 
donor organisms but can divide through multiple generations (50-100).25 Eventually, 
secondary cells will begin to change physically and die. Immortal cells on the other hand, 
will continue to grow and proliferate indefinitely given the optimal conditions. Typically, 
an immortal cell line consists of cells that have been transformed.25 This means that its 
growth properties have been changed by methods such as infection or gene manipulation. 




3.2.4.2 Transfection  
 
 Transfection is a DNA transfer process through which nucleic acids are delivered 
into cells by non-viral methods (infection). There are two categories of transfection, 
physical and chemical.27 Physical methods include direct microinjection,28 
electroporation29,30, and biolistic particle delivery31,32. Chemical methods include using 
chemical reagents such as dimethylaminoethyl-Dextran (DEAE-Dextran)33,34, calcium 
phosphate35,36, and artificial liposomes25,37. Though both categories of transfection 
methods are effective, physical methods tend to be laborious and are limited to 
transfecting only a small number of cells. For an example, it would be very cumbersome 
to inject (microinjection and biolistic delivery) every cell in a cultured plate. Additionally, 
with methods like electroporation, tuning and optimization of the strength and duration of 
the electrical pulse must be adjusted for each different cell line (typically used in plant 
cell lines). Hence, a chemical method of transfection was used in this thesis. 
 Since the cell membrane is negatively charged, the transport of negatively 
charged species across the membrane is either prohibited or retarded. Chemical methods 
take advantage of introducing net positive charges to allot for the transport across the 
membrane. When using DEAE-Dextran, the cationic polymer associates tightly with the 
backbone of DNA and facilitates the transport via endocytosis. Genes and gene fragments 
can also be precipitated with calcium phosphate co-precipitation methods where the 
precipitate is taken up through endocytosis or phagocytes. The most effective chemical 
method for transfection is through lipofection where nucleic acids are transported into 
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cells through complexing with artificial liposomes. A unique property of using artificial 
liposomes over other chemical reagent transfection methods is that it is applicable in vivo. 
 Lipofection was first introduced by Felgner et al. in 1987.37 Originally, a 
monocationic lipid was used to complex with DNA introducing a net positive charge on 
the complex. Through endocytosis the positively charged complex is taken up by the cells. 
This method was later improved by replacing the monocationic lipid reagent with a 
polycationic lipid38 or Lipofectamine.39 Lipofectamine is a liposome composed of 
polycationic lipid, 2,3-dioleyloxy-N-[2-(sperminecarboxamido)ethyl]-N, N,-dimethyl-1-
propanaminium tryfluoroacetate  (DOSPA) and a neutral lipid, 
dioleoyphosphatidylethanol-amine (DOPE).25 It is proposed that the  polycationic lipid’s 
role is to complexes with the backbone of the DNA introducing the positive charge while 
the neutral lipid’s role is to act as a “fusongenic”, enabling the release of nucleic acids 
from the endsomes in cell.40   
 Although the main purpose of transfection is to transfer DNA or fragments of 
DNA into cells, we have utilized this property to facilitate the delivery of our magnetic 
nanoparticles conjugated to oligonucleotides (mnp-oligo) into mammalian cells.   
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MODULATING THE MAGNETIC PROPERTIES OF COBALT SPINEL FERRITE 






 Varying concentrations of samarium have been doped into cobalt spinel ferrites to 
produce magnetic nanoparticles with the composition of CoSmxF2-xO4.  X-ray powder 
diffraction patterns of CoSmxF2-xO4 with an average particle size of 7.2nm did not reveal 
any significant changes in diffraction patterns relative to the native CoFe2O4 spinel 
structure. With varying doping percentages, insignificant changes in magnetic properties 
were observed. When compared to the native CoFe2O4 magnetic nanoparticle, a 
significant decrease in the saturation magnetization and increase in coercitivity was 
observed. A size variation study of Co Sm0.19Fe1.81O4 revealed a parallel increase in 
blocking temperature, Tb, and saturation of magnetization, Ms, but a non-linear trend in 
coercitivity, Hc. This study elucidated the tunability of the magnetic properties of cobalt 
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spinel ferrites via compositional changes by incorporation of rare earth metal such as Sm 





 The fundamentals and applications of nanoparticles have been explored 
extensively.1-4 Magnetic nanoparticles are typically known for information storage, 
magnetic resonance imaging (MRI), and more recently for a number of biological 
applications (see chapter 2 and references within). It is the unique superparamagnetic 
properties that render magnetic nanoparticles attractive for different application and 
investigation. Superparamagnetic properties such as their blocking temperature, 
coercitivity, and their saturation magnetization can be modulated by varying the  
compositional make up and the size of nanoparticles’.5-7 The ability to control the 
magnetic properties of nanoparticles is of fundamental interest in developing new and 
innovative materials.  
 Rare earth metals, well known for their interesting optical properties and chemical 
stability, have been noted as good candidates for the growing development of new and 
innovative magneto-optical recording media.7,8 The 14 inner transition elements are all 
chemically and structurally similar with a partially filled 4f shell with the exception of La 
and Lu.8 The magnetic moment of lanthanides can range from 0-10.5 µB and their 
variation in f electron configuration can introduce interesting magnetic interactions.8-14 
Optically, some lanthanide ions have an unusually long Stokes shift rendering them good 
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candidates for luminescence probes. For example, Eu3+ and Tb3+ luminesces green and 
red respectively when excited at wavelengths of about 296 nm.15 Additionally, Eu2+ 
luminesces blue. With different luminescence colors upon excitation, these lanthanide 
elements make good probes for oxidation states of targeted species.16  
 Of particular interest in this chapter is samarium. Like Eu3+ and Tb3+, Sm3+ have a 
long stoke shift as well and are used to as fluorescence markers when bound to chelating 
molecules.15  Samarium has five unpaired 4f electrons and has been used in applications 
ranging from carbon arc lighting for motion pictures to roles in stimulating metabolism.8 
Other examples include, samarium – cobalt magnets as one of the strongest types of 
magnets with an intrinsic coercive force that can be as high as 2200 kA/m.17 In addition, 
samarium oxide has been used in optical glass to absorb infrared light and for catalytic 
purposes to dehydrate and dehydrogenate ethanol.8 It has been shown that thin films of 
rare earth doped cobalt ferrites possess different magnetic properties of native cobalt 
ferrite films. For example, Cheng et. al. observed that there is an antiparallel relationship 
between the Curie temperature and the concentration of rare earth doped in cobalt spinel 
ferrite films prepared by sol-gel methods.7 They also observed a reduction in magneto – 
optical rotation with increasing doping percentages of rare earth metals. More recently, 
our group began investigating methods of controlling the magnetic properties of cobalt 
spinel ferrite nanoparticles using rare earth metals through an oil-in-water synthesis 
method. Previously, we demonstrated that a set of lanthanides (Sm, Ce, Eu, Gd, Er, Dy) 
doped in cobalt spinel ferrites resulted in dramatic variation of magnetic properties when 
different lanthanide ions were incorporated.6 The variation of blocking temperature, 
saturation magnetization, and coercitivity with different doped lanthanide ions prompted 
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a further interest for a systematic study. In addition, we recognized that samarium, like 
other rare earth metals, are less likely to be present in biological buffers, making them a 
unique marker when they are present. In this chapter, a systematic study on samarium 







 Cobalt spinel ferrites, CoFe2O4, were synthesized using a normal micelle method 
previously described.18 Cobalt-samarium spinel ferrites were also synthesized using the 
normal micelle method with slight modification.6,18 Briefly, stoichiometric amounts of 
CoCl2⋅4H2O: x SmCl3⋅6H2O: 2-x FeCl2⋅4H2O (x = 0 – 0.187) were mixed in sodium 
dodecyl sulfate (SDS) then chilled to 10°C in an ice bath.  Aqueous methylamine 
(~11mol) was added at 10°C and the mixture was then heated to 75°C ± 5°C for two to 
three hours. Nanoparticles were then isolated via centrifugation followed by washing 
with distilled water then with a 20% v/v aqueous ethanoic solution. The final product was 








 X-ray powder diffraction patterns of CoFe2O4 and CoSmxFe2-xO4 were collected 
using a Bruker D8 Advance Diffractometer with a CuKα line. Transmission electron 
micrographs were primarily taken to verify the size estimated by XRD. Magnetic 
properties of CoFe2O4 and CoFe2-xSmxO4 spinel ferrite nanoparticles were measured 
using a Quantum Design MPMS-5S superconducting quantum interference device 
(SQUID). An applied field of 100G was applied in susceptibility experiments that swept 
from 5-300K or 300-500K. Hysteresis measurements were measured at 5T at 5K unless 
otherwise designated. Doping percentages were confirmed by digesting CoSmxFe2-xO4 
with 40% nitric acid (trace metal grade) then diluting to 1% HNO3 final concentration 
before introducing into a Perkin-Elmer Optima 3000 ICP-OES system. 
 
4.3 Results and Discussion 
 
 This systematic study was broken down into two categories, variation in percent 
composition and size variation studies. In the first category, the average size of the 
particle was kept constant (average particle size of 7.2nm) while the percent composition 
of the magnetic nanoparticle was varied resulting in the formula of CoSmxFe2-xO4 (x = 0 
– 0.19). In the second category, the percent composition of the magnetic particles was 




4.3.1. Composition variation 
 
 X-ray powder diffraction patterns of CoSmxFe2-xO4 were collected at the 2θ range 
of 15-85°. The diffraction pattern indicated a spinel phase and mirrored that of CoFe2O4 
(Figure 4.1). Therefore, the introduction of Sm3+ did not change the lattice constant. Size 
of the nanoparticles determined from the peak broadening using Scherrer’s equation 
correlated well with size determined through TEM images. The average size of 
CoSmxFe2-xO4 used for comparison was 7.2nm with a size distribution up to 15%. The 
chemical composition of CoSmxFe2-xO4 was determined with ICP-OES. Elemental 
analysis data collected for CoSmxFe2-xO4 identified x = 0 – 0.19. 
 Magnetic characterization of CoSmxFe2-xO4 ( x = 0 – 0. 19) illustrated that there is 
a general consistency of Tb within the samples examined (See Table 4.1 and Figure 4.2). 
In Figure 4.2, the peak of each individual curve represents the blocking temperature. 
Above this temperature, magnetic moments have enough thermal activation to overcome 
the energy barrier for magnetization reversal. Hence above the Tb the susceptibility 
begins to decrease as moments behave like paramagnetic materials but with stronger 
magnetization. From Table 4.1 and Figure 4.3, information regarding the Ms 
(magnetization saturation) and Hc (coercitivity) of CoSmxFe2-xO4 is revealed. As the 
magnetic field is ramped from zero to 50,000 Oe then back to zero, remnant 
magnetization forms a “memory” effect, hysteresis. An opposite field is required to force 
the magnetization back to zero with an opposite field. The amount of magnetic field 
required to return the magnetization to zero is referred to as coercitivity.  When all of the 




























Figure 4.1   XRD pattern of CoSmxFe2-xO4 compared to native CoFe2O4. Diffraction 
patterns of CoSmxFe2-xO4 do not show any significant difference when compared to 
CoFe2O4 indicating that a correct spinel phase has been accomplished. Intensities were 
intentionally offset to demonstrate the similarity in patterns between samarium doped 
cobalt spinel ferrites and native cobalt spinel ferrite magnetic nanoparticles.    
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Sm doped cobalt spinel ferrite samples, a relatively small change in Ms and Hc was 
observed (see Table 4.1 and Figure 4.3). However, when the Ms and Hc of doped particles 
were compared to native particles, CoFe2O4, there is a clear difference.  The Ms of the 7.2 
nm sized CoSmxFe2-xO4 were all in the general range of about 34 – 40 emu/g⋅Oe which is 
a marked decrease when compared to the Ms of CoFe2O4 at 68.4 emu/g⋅Oe. Even if 10-
15% instrument error is accounted for, the doped and undoped Ms values differ 
dramatically. The Hc of this series of CoFSmxe2-xO4 had less than one kOe change within 
samples ranging from x>0 but is on average about 4.9 kOe higher than that of CoFe2O4 
(Hc = 11.0 kOe). When measurements are made at temperatures above the blocking 
temperature, hysteresis disappears (Figure 4.4) because there is enough energy to 
overcome the magnetization reversal energy barrier allowing moments to line up with the 




 Table 4.1  Summary of magnetic characteristics of CoSmxFe2-xO4. 
Sample Tb (K) Ms (emu/g) Hc (KOe) 
CoFe2O4 305.6 69.8 11.0 
CoSm0.03Fe1.97O4 273.4 39.6 15.8 
CoSm0.05Fe1.95O4 271.6 39.3 15.1 
CoSm0.14Fe1.86O4 322.7 34.4 15.7 
CoSm0.19Fe1.81O4 283.4 37.5 15.7 
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From the Stoner – Wohlfarth theory19, we know that the energy barrier for magnetization 
reversal can be represented by 
   
                EA = KVsin2θ                                                   (4.1) 
 
where EA is the energy barrier for magnetization reversal, K is the magnetocrystalline 
aniosotropy constant, V is the volume of the nanoparticle, and θ is the angle between the 
direction of magnetization and the easy axis of the nanoparticle.19 Since the blocking 
temperature is the threshold and the point at which magnetic nanoparticles become 
superparamagnetic, it will be reflected by nanoparticle size. The evaluated samples in this 
category were of very similar sizes and hence, the volume of these nanoparticles is very 
similar. Therefore, the insignificant changes in Tb were expected and correlated well with 
theory. 
 The large coercive force of CoFe2O4 has been proposed to originate from the 
single-ion anisotropy of Co2+ ions in the octahedral sites.7 Neutron diffraction study show 
that CoFe2O4 is a mixed spinel with approximately 72% inversion for cation 
occupancy.18,20 Since most lanthanide ions have relatively large absorption cross sections, 
common neutron scattering studies for Sm3+ were not done. Previous neutron diffraction 
studies of La3+ doped cobalt spinel ferrites showed that all of the doped ion resides in the 
octahehral sites and replaced only Fe3+ ions. 18,20 Since the ionic radius of La3+  (117 
pm)16 is similar to the ionic radius of Sm3+ (110 pm)16, we postulate that all of the Sm3+ 


































Figure 4.2 Varying percent Sm doped susceptibility vs. temperature plot of a series of 
7.2nm CoSmxFe2-xO4 (x = 0, 0.03, 0.09, 0.14, 0.19) magnetic nanoparticles. The blocking 





































Figure 4.3  Hysteresis loop of 7.2nm CoSmxFe2-xO4 magnetic nanoparticles at 5K. The 
magnetic field is ramped from zero to 50 kOe then to the same magnitude but in a 
different direction. Once at the magnetization saturation point, where moments align with 
the direction of the applied field, the reversal of magnetic moments generates a hysteresis 
loop. The introduction of samarium into cobalt spinel ferrite reduces the Ms and increases 
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Figure 4.4 Hysteresis measurement of CoSm0.19Fe1.81 at 300K. Above the blocking 
temperature of CoSm0.19Fe1.81 (283.4K), there is enough thermal energy to overcome the 
EA allowing reversal of magnetization, hence there is an absence of hysteresis. 
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spin-orbit coupling that leads to large magnetocrystalline aniosotropy.8 Hence, Sm3+has a 
very high coercive force and adds to the coercive forces of cobalt spinel ferrites.  Results 
showed an increase in coercitivity when CoSmxFe2-xO4 is compared to CoFe2O4. Within 
varying amounts of Sm3+ ion doped, an negligible change in coercitivity was observed. 
Since the doping concentration change of Sm3+ is relatively small, the change in 
coercitivity is not as obvious and most likely insignificant. When hysteresis 
measurements are made above the blocking temperature, hysteresis disappears as evident 
in Figure 4.4, which is characteristic of superparmagnetic nanoparticles. Above the 
blocking temperature, there is enough energy to overcome the magnetocrystalline 
anisotropy barrier allowing the moments to align with the magnetic field.  
 Abstracting from the Stoner – Wolhfarth theory, the coercitivity of nanoparticles 
can be determined by 
 
      Hc = 2K/(µ0Ms)                                         (4.2) 
 
where K is the magnetocrystalline anisotropy constant and µ0 is a universal constant of 
permeability in vacuum. So if we rearrange this equation to 
 
                Ms = 2K/(µ0Hc)                                                  (4.3) 
 
then a decrease in Ms is expected with an increase in Hc. Observation definitely showed a 
decrease in Ms when samarium doped cobalt ferrite was compared to the undoped cobalt 
ferrite but less defined changes in the Ms were observed within doped samples. Once 
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again, since the difference between the concentration of Sm3+ doped in CoFeSmxFe2-xO4 
is relatively small, the changes in saturation magnetization are relatively small and 
negligible. 
 
4.3.2 Size variation 
 
 In this second category, the size of CoSm0.19Fe1.81O4 was varied from 4.7nm - 
12.5nm.  Elemental analysis with ICP-OES confirmed the composition ratio of CoSm-
0.19Fe1.81O4. X-ray diffraction patterns (Figure 4.5) mirrored those of native CoFe2O4 
(refer to Figure 4.1 for native CoFe2O4 diffraction pattern) indicating the presence of the 
spinel phase.  Since the diffraction patterns were essentially the same, we can assume that 
introduction of Sm3+ did not change the lattice constant.  Sizes of CoSm0.19Fe1.81 
nanoparticles were determined from the peak broadening in XRD patterns using 
Scherrer’s equation and correlated well to sizes determined with TEM images. Size 
control of cobalt spinel ferrites has been established in previous studies18 and similar 
synthetic procedures were used to vary the sizes of CoSmxFe2-xO4. To determine the 
blocking temperature of these magnetic nanoparticles, a low temperature range, 5K-
300K, at 100G, was applied. Additionally, for the 12.5nm CoSm0.19Fe1.81O4, a high 
temperature range, 400K-500K, at 100G was used.  
 From the results (see Table 4.2 and Figures 4.6-4.7), we can draw that there is an 
increase Tb parallel to the increase in nanoparticle size. Likewise there is a increase in Ms 
with increased size. A non-linear trend was observed for Hc with size variation. Initially, 
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there is an increase in Hc with increasing size but then it decreases with further increase 
in size of the magnetic nanoparticles.  
 The increase in Tb with increasing size is an anticipated increase based on the 
Stoner-Wohlfarth theory (see equation 4.1). From equation 4.1 we can see the correlation 
between size and EA. An increase in the size of nanoparticles will increase volume, 
hence, it will increase the EA. Likewise, a decrease in the volume of the nanoparticle will 




Table 4.2.  Magnetic characteristics of CoSm0.191Fe1.809O4 of various sizes. 
Size (nm) Tb Ms Hc
4.7 201.9 21.7 8.8 
7.0 272.4 31.5 16.9 
10.0 346.6 59.5 10.9 



























Figure 4.5  XRD pattern of various sized CoSm.0191Fe1.981O4. The intensities were 
intentionally offset to demonstrate the similarity in patterns.  Inset shows a TEM 

































Figure 4.6  Size variation susceptibility vs. temperature plot of CoSm.019Fe1.81O4. For the 
12.5 nm CoSm0.19Fe1.81O4 curve, it is actually made up of two curves, one ranging from 
5-400K and another from 400-500K. The maximum susceptibility point or peak of the 





























Figure 4.7 Hysteresis loop of various sized CoSm.0191Fe1.981O4 at 5K, 5T. The magnetic 
field is ramped from zero to 50 kOe then to the same magnitude but in a different 
direction. Once at the magnetization saturation point, where moments align with the 
direction of the applied field, the reversal of magnetic moments generates a hysteresis. 
From the different hysteresis loops, there is a direct correlation between size and Ms. An 
increase in size produced higher magnetization saturation points and vice versa for 
smaller sizes. Coercitivity initially increases with size then decreases with increasing 
size. This may be attributed to initial coherent rotation of magnetic moments followed by 
spin canting. 
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 As the size of the magnetic nanoparticles is decreased, the anisotropy is 
decreased. The decrease in anisotropy  should decrease the Hc but this linear trend was 
not observed. From the hysteresis loop (Figure 4.7), an initial increase followed by 
decrease in Hc was observed. This initial increase may be due to coherent magnetization 
while the eventual decrease may be attributed to other surface effects. This type of Hc 
trend was also observed in CoFe2O4 systems synthesized through seed mediated non-
hydrolytic process.21 The saturation magnetization decreased with decrease in size of the 
nanoparticles and can be attributed to spin-canting where the magnetic disorder of the 
moment increases when the particle size decreases and the surface to volume ratio 
increases.22-24 The observed Ms data corresponded well to other reported saturation 
magnetization trends showing a parallel change in saturation magnetization with change 





 We have shown here a method of modulating the magnetic properties of CoFe2O4. 
By doping CoFe2O4 with rare earth metals like samarium, we can alter the blocking 
temperature and its saturation magnetization as well as its coercitivity through 
composition and size change. Using different samarium doping percentages, saturation 
magnetization can be altered by as much as 35.3 emu/g.Oe and the coercitivity can be 
altered by as much as 4.8 kOe relative to the undoped particle while maintaining similar 
blocking temperatures. By changing the size of the nanoparticle and maintaining a 
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constant composition, the blocking temperature can be tuned as well. This systematic 
study proves that the magnetic behavior and intrinsic properties of CoFe2O4 can be tuned 
by addition of samarium. Fundamentally, the ability to finely tune the magnetic 
properties is of importance. However, the importance of utilizing these tunable magnetic 
nanoparticles for developing novel materials with adjustable parameters should not be 
underestimated. There is ample room to explore the properties of novel materials with 
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CELLULAR UPTAKE AND MAGNETIC MANIPULATION OF COBALT SPINEL 






Through surface modifications, magnetic cobalt spinel ferrite nanoparticles, 
CoFe2O4, have been conjugated to oligonucleotides and transfected into African green 
monkey kidney cells (CV-1) and Henrietta Lacks cervical cancer cells (HeLa) using 
LipofectamineTM.  Sectional laser scanning confocal microscopy studies indicate that 
transfected CoFe2O4-oligonucleotide conjugates are localized within the cell. An adverse 
effect on cell growth was not observed up to 250 hours post transfection. Movement of 
transfected cells in buffer solution towards an external magnetic field as well as 
fluorescent illumination in the middle sections of cells demonstrates the feasibility of 
using CoFe2O4 for magnetic manipulation of cells. Quantification of cellular uptake 
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efficiency of CoSm.0.14Fe1.86O4 – oligonucleotide conjugates using ICP-OES as a model, 




Cellular trafficking is of great importance in the fundamental understanding of 
cell biology and plays a central role in the delivery of drugs into living cells. A variety of 
techniques have been developed to improve the transport of poorly permeable molecules 
across the cell membrane. Protein transduction has been demonstrated to be a promising 
method for delivering a variety of objects such as small molecule drugs, proteins, and 
even nanoparticles. Conjugation with peptides and oligocarbamates effectively enhances 
the uptake of model drugs into cells.1,2 Gold nanoparticles with a diameter of 20 nm were 
transported into HepG2 cells after being coated with a shell of bovine serum albumin 
conjugated to a variety of peptides.3 Similarly, by using a HIV-tat protein peptide 
derivative, dextran-coated magnetic nanoparticles of iron oxides were introduced into 
several cell types such as lymphocyte and HeLa cells. Upon uptake of magnetic 
nanoparticles, the labeled cells can be readily tracked in vivo by magnetic resonance 
imaging (MRI).4-6 Magnetic labeling of cells offers a number of other applications 
including bio-distribution studies of nanoparticulate carriers in vivo7,8 and cell separation 
in vitro or in vivo.9-12 
With the increasing focus on drug and gene delivery, magnetic nanoparticles have 
great potential for site specific targeting. Using an external magnetic field, magnetic 
nanoparticles carrying cargos such as drugs or genes can potentially be guided to or close 
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to the site of target cells in vivo. An added benefit of using magnetic carriers is the 
possibility of localizing or restricting the bioconjugates to a specified region with an 
external magnetic field. Recently, an increasing number of studies have been directed 
towards the investigation of the cellular uptake of magnetic nanoparticle-protein13,14 and 
magnetic nanoparticle-peptide4-8,15-18 conjugates.  However, the magnetic nanoparticles 
used were typically magnetite, Fe3O4, or other less defined magnetic nanoparticles. 
Although magnetite nanoparticles have displayed interesting and useful properties as 
MRI contrast enhancement agents (e.g. Feridex®), they are relatively weak magnetically 
when compared to other spinel ferrite nanoparticles like CoFe2O4 and MnFe2O4. Using 
nanoparticles with weak magnetic responses could introduce difficulties when magnetic 
manipulation and control is necessary. Although CoFe2O4 and MnFe2O4 nanoparticles 
clearly posses advantages in terms of magnetic properties and magnetic interaction, only 
a few studies on their application in biological systems and their possible adverse effects 
on living organs have been explored.  
 This chapter focuses on the potential of CoFe2O4 nanoparticles as magnetic 
carriers for therapeutic reagents, specifically, oligonucleotides. Transfection of cobalt 
spinel ferrite, CoFe2O4, magnetic nanoparticle-oligonucleotide conjugates into African 
green monkey kidney epithelial cells (CV-1) and Henrietta Lack human cervical cancer 
epithelial cells (HeLa) will be discussed. Results illustrate that lipofection, as a method of 
cationic lipid-mediated DNA transfection, is an effective way to deliver nanoparticles 
into cells. Observations show that CoFe2O4 – oligonucleotides did not affect the 
proliferation cycle or induce any obvious morphological changes. The magnetic response 
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of CoFe2O4 internalized by cells is clearly defined by the synchronized cellular 




5.2.1 Cell Lines and Medium Preparation 
 
 Henrietta Lacks cervical cancer cells, HeLa, were first isolated from the cervix of 
Henrietta Lacks back in 1951. Since then numerous research studies have been conducted 
sometimes with unreliable data. Since HeLa cells are immortal cells and grow very 
rapidly in cell cultures, they tend to invade other cell lines if careful aseptic practice is 
not observed. Karyotype analysis show that there are actually multiple different HeLa 
cell types. This can be attributed to the malignancy of the cell and it progress in different 
environment. Due to the variables that can be generated from one batch of cells to 
another in malignant cells, most cellular analysis experiments are now conducted with 
both malignant and non-malignant cells for comparison. 
 African green monkey cells, CV-1, are cultivated from the kidney epithelial cells 
of male African green monkeys. These are non-malignant primary cells that have been 
cultivated to grown continuously through several generations. Since they are primary cell 
lines, after a finite number of generations, CV1 cells will no longer proliferate normally 
or may cease to proliferate. However, since they are non-malignant and easy to transfect, 
they are good candidates for cellular analysis experiments.   
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 Green monkey kidney cells and human cervical cancer cells were grown and 
passaged in Dubelcco’s Modified Eagles Medium (DMEM) supplemented with 10% 
defined bovine calf serum (CBS) and 1% penicillin streptomycin.  Both basal mediums 
were sterile filtered with a 0.2µm pore size filter. During transfection, an indicator free 
media with significantly reduced serum, OptiMem, was used to reduce possible reactions 
with sera proteins.  
 
5.2.2 Preparation of Magnetic Nanoparticle – Oligonucleotide Conjugates 
 
 The target is to functionalize cobalt spinel ferrite or samarium doped cobalt spinel 
ferrite nanoparticles with a functional group that will act as a point of attachment to 
macromolecules like DNA. Superparamagnetic CoFe2O4 and CoSm0.14Fe1.86O4  
nanoparticles were synthesized using a normal micelle method (see Chapter 4.2.1).19  The 
surface of 10nm magnetic nanoparticles were first activated with concentrated NaOH 
then functionalized with epichlorohyrin followed by amination with NH4OH. Amine 
functionalized magnetic nanoparticles were then isolated through several washes with 
DMSO and magnetic separations.  Subsequently, a commercially available linker group, 
N-succinimidyl 3-2[pyridyldithiol]proprionate (SPDP), was attached to the surface 
through an amide bond. Magnetic nanoparticles-SPDP conjugates were then subjected to 
several washes with phosphate buffered saline (PBS), magnetically separating after each 
wash.    Thiol-terminated oligonucleotide with a random sequence of 5’-HS-(CH2)6-GTA 
AAA CGA CGG CCA GAG-3’ (oligonucleotide  1) or oligonucleotide 3 (5’-HS- AAA 
CGA CGG CCA GAG-3’-FAM) were reduced with Cleland’s reagent (immobilized 
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dithiolthreitol) and then attached to the surface through a thiol exchange reaction with the 
surface crosslinker overnight. Oligonucleotides of the magnetic nanoparticle – 
oligonucleotide 1 conjugates were then hybridized with their complimentary strand 
tagged with fluorescein, 5’-CAC TGG CCG TCG TTT TAC – 3’ – FAM 
(oligonucleotide 2) in PBS at temperatures above is melting temperature (Tm = 60°C)  for 
30 minute and then allowed to cool to room temperature slowly so the two strands can 
anneal. Hybridized magnetic nanoparticle – oligonucleotide 1-2 conjugates resulted in a 





Figure 5.1 Schematic representation of the crosslinking chemistry behind mnp-oligo 
conjugates. An amino functionalized magnetic nanoparticle is reacted with the maleimide 
group of SPDP leaving the thiol reactive terminus of the crosslinker exposed and 
unreacted. In the presence of reduced thiol-terminated oligonucleotides, a thiol-thiol 
exchange between the thiol terminus of the oligo and the disulfide bond of the crosslinker 
occurs forming a new disulfide bond.  
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the formula of CoFe2O4 – oligo 1-2 or CoSm0.14Fe1.86O4– oligo 1-2 (see Figure 5.1).  
Magnetic nanoparticle – oligonucleotide 3 was transfected along with and additional 
100ng of β-Galactosidase reporter gene for a total of 300ng of DNA. 
 
5.2.3 Transfection of Magnetic Nanoparticle – oligonucleotide conjugates into 
Cells.  
 
 As specified earlier, there are multiple methods for cellular delivery of genes. We 
have chosen to use transfection. There are two classes of transfection, physical and 
chemical transfection. Direct microinjection, electroporation, and biolistic particle 
delivery are all physical methods. With direct microinjection, as its name implies, genes 
are directly injected into cells. For example, Cappechi demonstrated that using 
microinjection methods, DNA can be transferred to stem cells.20 Electroporation is 
primarily used for plant cells where an electrical pulse is used to perturb the membrane 
for DNA transfer.21 In bioloistic methods, genetic material is transferred into recipient 
cells via a high velocity microprojectile.22  Physical transfection relies on physically 
transferring the DNA into individual cells and is labor intensive, especially for a high cell 
count. Chemical transfection is more appropriate for DNA transfer into many cells. 
Examples of chemical transfection include DEAE-dextran association, co-precipitation 
with calcium phosphate, and transfection facilitated by artificial liposomes. Using DEAE-
dextran, an excess of positive charge is introduced allowing DNA electrostatically 
associated with DEAE-dextran to be chaperoned into cells.23,24 Through enodcytosis, 
calcium chloride / DNA co-precipitates can be taken up. Artificial liposomes, introduced 
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in the late 1980s, offer high transfection efficiency and can be used with cell lines that do 
not tolerate other chemical transfection reagents.25 Due to the high popularity of artificial 
liposome, readily available protocols and reagents have been established.26,27  
 Lipofectamine™, a commercially available synthetic polycationic lipid was used 
as the transfecting agent to facilitate the transport of cobalt spinel ferrite – oligo 
conjugates and samarium doped cobalt spinel ferrite – oligo conjugates across the cell 
membrane. Lipofectamine™ has a chemical makeup of 3:1 ratio 2,3-dioleylexy-N-
[2(sperminecarboxamideo)ethyl]-N,N-dimethyl-1-propanamium trifluoroacetate  (DOPA) 
and dioleyl phophatidylethanolamine (DOPE).28 Lipofectamine™ is supplied as a 
concentrated solution so it was diluted with OptiMem (a reduced serum media) before 
use then allowed to complex electrostatically with the oligonucleotides on the surface of 
CoFe2O4. This complex was then introduced to cells grown on glass coverslips in a 
reduced serum media for approximately 7-10 hours at 37°C and 5% CO2. After 
internalization, the media was replaced with a growth media, DMEM supplemented with 
10% Calf Bovine serum and 1% Penicillin Streptomycin glutamate. An illustration of the 
transfection method used can be seen in Figure 5.2. For the 96hr and 250 hr studies, cells 
were trypsinized then passaged and grown in a new plate on coverslips. 







Figure 5.2  Illustration of the general protocol for transfection with Lipofectamine™. 
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5.2.4 Transfection Control Experiments 
 
 Several sets of control experiments were conducted to ensure that observations 
and interpretations made were conclusive. To demonstrate that transfection reagents are 
required to transport negatively charged species across the membrane, control 
experiments were carried out without Lipofectamine.™ In the first category, CV -1 cells 
were incubated with either (a) CoFe2O4 nanoparticles, (b) CoFe2O4 mixed with 
fluorescein labeled oligonucleotides, or (c)  cobalt spinel ferrite conjugated to fluorescein 
labeled oligonucleotide were incubated with cells in OptiMem®. To demonstrate that 
only CoFe2O4 – oligonucleotide conjugates were being taken up by cells when 
Lipofectamine™ is used, (a) CoFe2O4 nanoparticles, (b) CoFe2O4 mixed with 
oligonucleotides, or (c) fluorescein labeled oligonucleotides were allowed to complex 
with Lipofectamine™ then incubated with CV -1 cells in OptiMem®.  
  
  
5.2.5 Confocal Microscopy and Dark Field Microscopy 
 
 To ensure that cells grown on coverslips retain their cellular constituents, 
“fixation” is required. When cells are removed from their native or optimal condition, 
autolysis initiates. In autolysis, intracellular enzyme begins to breakdown the proteins in 
the cell eventually liquefying the cell.29,30 There are many choices of fixatives available, 
such as aldehydes, osmium tetroxide, chromic acid, alcohol, mercuric chloride, and 
acetone.  The most commonly used fixative is a low concentration formaldehyde solution. 
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A 4% p-formaldehyde solution was used in this study. The fixation mechanism is not 
well understood but proposed to be some sort of crosslinking reaction between the 
aldehyde and proteins through amino acids and functional groups such as amido, 
guanidyl, carboxyl, SH, and hydroxyl groups on protein surface.29 The crosslinking 
provides mechanical strength retaining cellular constituents during progressive 
experimental steps. In the experiments described in this chapter, growth medium is 
removed then cells are washed with PBS. Next, they are immersed in a buffered 4% 
paraformaldehyde, gently agitated for 15-20 minutes, and then rinsed with PBS before 
mounting onto microscope slides with Paramount G (to reduce in photobleaching of 
fluorescence).  A Zeiss confocal microscope housed with Argon laser was used for 
imaging cells transfected with magnetic nanoparticle – oligo conjugates. Since confocal 
microscopy allots for multiple plane focusing, z-stack or z-sectional images were 
collected at set micron increments, typically at 1.0 – 2.0 µm increments. This provided 
information on the approximate location of the CoFe2O4 – oligo conjugates in the cell. 
Sample preparation for darkfield microscopy was essentially the same as those for 
confocal microscopy except coverslips were directly mounted onto microscope stage. 
Dark field micrographs of the native cells, CoFe2O4 – oligo conjugates, and of cells 
transfected with CoFe2O4 – oligo conjugates were taken with a Olympus IX 70 inverted 






5.2.6 Inductively Coupled Plasma – Optical Emission Spectrometry of Uptaken 
Magnetic Nanoparticle.  
 
 CV-1 cells transfected with CoSm0.14Fe1.86O4– oligoX  (X = 1-2 or 3)  were 
washed thoroughly, trypsinized, suspended in buffer, then manually counted on a 
hematocytometer (see Figure 5.3). Cell suspensions were then stored in a freezer 
overnight then thawed before use. This extreme change in environment causes cells to 
lyse. Cell suspensions were then magnetically separated, washed with 1% HNO3, and 
magnetically separated. The magnetically separated precipitate was then digested in a 
parbomb with HNO3 (trace metal grade) at 120°C for 24 hours. The digested sample was 






Figure 5.3 Grids of a hemacytometer. The number of cells in region 5 represents the 
number of cells, n, present in 0.1 µL. Hence, the total number of cells per 1 mL is n x 104. 
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5.3 Results and Discussion 
 
5.3.1 Crosslinking of CoFe2O4 to oligonucleotides 
 
 Using a commercially available heterofunctional crosslinker, SPPD, with amine 
and thiol reactive termini, we have crosslinked oligonucleotides to the activated surface 
of magnetic nanoparticles. As mentioned in the section 5.2.2, activation CoFe2O4 
followed by reacting with epichlorohydrin then amination with NH4OH yielded magnetic 
nanoparticles with an amine functionalized surface. Amine is then reacted with the 
maleimide group of SPDP leaving the thiol terminus reactive. Oligonucleotides with thiol 
modifications were then reduced and attached to the surface through a thiol-thiol 
exchange. We did not verify the surface coverage of oligonucleotides on CoFe2O4 
nanoparticles but estimate that it should resemble the grafting density of benzoic acid on 
CoFe2O4 nanoparticles (1.20 molecules/nm2).31  
 
5.3.2 Lipofection of CoFe2O4 – oligonucleotide conjugates into HeLa and CV-1 
cells 
 
 The internalization of CoFe2O4 – oligonucleotide conjugates by HeLa and CV-1 
cells were monitored by the fluorescence from the fluorescein tag on oligonucleotides. 
Using a confocal microscope, z-stack images were taken at 1-2 µm interval starting from 
the bottom portion of the cell to the top portion of the cell. From the overlaid 
(fluorescence over brightfield) image in figure 5.4., the presence of fluorescence at the 
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middle sections of the cell and the absence of fluorescence at the beginning and latter 
sections of the cell indicated that CoFe2O4-oligonucleotides are internalized by HeLa 
cells. Similarly, the same pattern of luminescence can be observed in CV-1 cells (Figure 
5.5). For comparison purposes, native HeLa and CV-1 cell confocal micrographs are 
shown in Figures 5.6 and 5.7.  To verify that the dark spots, seen in the cytoplasm, in all 
of the confocal overlay images were aggregates of CoFe2O4, we repeated the transfection 
experiment and took darkfield micrographs of native CV-1 cells, CoFe2O4 – oligo 
clusters, and CV – 1 cells transfected with CoFe2O4 – oligos (Figure 5.8). Based on the 
darkfield micrographs, it is clear that the dark spots we see in confocal micrographs 
correlates to clusters of aggregated magnetic nanoparticles. Additionally, we also 
transfected CV-1 cells with CoFe2O4 – oligo conjugates where oligonucleotides were not 
fluorescently labeled. Confocal micrograph taken at 1µm interval showed dark spots 
within the cytoplasm and around the nucleus (see Figure 5.9) similar those seen in other 
confocal micrographs of cells transfected with CoFe2O4 – oligo conjugates. 
 To verify that the CoFe2O4 – oligo conjugate remained intact during lipofection 
and to demonstrate the magnetic control, parallel experiments were carried out but 
instead confocal images, brightfield and/or fluorescent images were collected. Cells were 
detached from the coverslip to form a suspension then magnetically separated and 
washed with PBS. Using a small laboratory Nd-Fe-B magnet, brightfield images of cells 
moving in response to a magnetic field was observed (Figure 5.10). We repeated the 
experiment taking several hundred frames (millisecond intervals) of the cells responding 
to the magnetic field and collectively constructed a short movie in Figure 5.11 
































































































Figure 5.8 Darkfield micrographs of (a) native CV – 1 cells, (b) CoFe2O4 – oligo clusters, 






















































































Figure 5.10  Synchronized movement of HeLa cells 




Figure 5.11 Movie of cells responding to the magnetic field. 
(heintz_eva_l_200412_phd_magneticmovement1.mpg    Click tag           ) 
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collected with a fluorescence microscope, the presence of green luminescence in the cells 
confirms that the oligonucleotides remained intact during transfection. Based on 
calculations (see Appendix A), the amount of magnetic force exerted by the magnet on 
each cell 5.08 cm away (magnetic gradient of 6.4 T/m) in a static environment is 
estimated to be 61.1 x 10-17 N. The hemadynamic force that counteracts the magnetic 
force is estimated to be 1.42 nN. Hence, it is not likely that these magnetic nanoparticles 
can be controlled in a flowing system. The proximity of the source of magnetic field to 
the target needs to closer (around 1 cm) and the applied field must be greater than 0.3 T 
for localization of magnetic carriers in a blood capillary flow rate. 
 Several sets of control experiments were conducted to ensure proper interpretation 
of data. When CoFe2O4 nanoparticles were incubated with CV -1  cells in OptiMem® 
without Lipofectamine™, uptake was not observed by the absence of movement with an 
external magnetic field. When CoFe2O4 nanoparticles were mixed with fluorescence 
labeled oligonucleotides or conjugated to fluorescence labeled oligonucleotides then 
incubated with cells in OptiMem® without Lipofectamine™, absence of movement with 
magnetic field was observed. In addition, fluorescence was not observed in any confocal 
micrographs. These results indicate that a facilitating reagent like Lipofectamine™ is 
required to deliver negatively charged species across the membrane.   
 When CoFe2O4 nanoparticles were mixed with Lipofectamine™ then incubated 
with cells in OptiMem®, a magnetic response to an external magnet was not observed 
indicating that nanoparticles were not taken up by cells. This means that CoFe2O4 
nanoparticles are not be complexed to the liposomes, hence, they are not transported into 
cells. As discussed in the section 5.2.3, Lipofectamine™ facilitates the transport of genes. 
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To confirm that Lipofectamine™ is not facilitating in the transport of CoFe2O4 
nanoparticles in the presence of free oligonucleotides, CoFe2O4 nanoparticles were mixed 
with fluorescein labeled oligonucleotides, complexed to Lipofectamine™, then incubated 
with host cells. Confocal micrograph (Figure 5.12) showed luminescence but a cell 
suspension for this control experiment did not exhibit any magnetic response. Hence, the 





Figure 5.12 Confocal micrograph of CV-1 cells incubated transfected with CoFe2O4 






For further verification and comparison, fluorescein labeled oligonucleotides without 
nanoparticle were allowed to complex to liposomes then incubated with host cells. Once 
again, the confocal micrograph indicated fluorescence (Figure 5.13) and as expected, the 
cell suspension of this control experiment did not exhibit a magnetic response to an 





Figure 5.13 Confocal micrograph of CV-1 cells transfected with fluorescein labeled 





 To investigate the transfection efficiency, transfection experiments of CoFe2O4 – 
oligonucleotide conjugates were repeated. Based on visual inspection with fluorescence 
image shown in Figure 5.14, an efficient transfection can be estimated. Initial 
quantification by flow cytometry of fluorescence population versus native cells provided 
inconclusive results. Furthermore, flow cytometry relies on fluorescence. We are 
primarily interested in the number of nanoparticles taken up along with the 
oligonucleotides attached. To quantify the efficiency, lipofection of CoSm0.145Fe1.855O4– 
oligo conjugates into CV-1 cells was carried out to mimic the transfection of CoFe2O4 – 
oligonucleotide conjugates. Samarium doped cobalt spinel ferrites, CoSm0.145Fe1.85504, 
were chosen since Sm ions are not present in the medium that cells are cultivated in and 
behave similarly to CoFe2O4. From ICP results, we calculated based on Co and Fe that 
the number of CoSm0.14Fe1.86O4  taken up by CV-1 cells is  2.74 x 108 particles and 2.89 
x 108 particles respectively. That is a ten fold increased efficiency compared to the 
reported 1.27 X107 Fe particles per cell.32  However, since, ICP is a trace metal analysis 
instrument, the possibility of preexisting Co and Fe present may inflate the actual 
concentration of Co and Fe detected. To eliminate such erroneous results, we chose to 
detect samarium. From ICP-OES, we calculated that the amount of Sm present in each 
cell is 4.44 x 107 CoSm0.14Fe1.86O4. This is almost a four time improvement to the highest 





Figure 5.14 Fluorescence micrograph of CV-1 cells transfected with 
CoFe2O4 – oligonucleotide conjugates demonstrating the transfecting efficiency. 
 
 
 For the purpose of monitoring possible adverse effects that may be imposed on 
cells post transfection, confocal micrographs of transfected cells were taken 24hrs, 48hrs, 
96hrs, and 250hrs post transfection (see Figure 5.15). By comparing Figures 5.15a-d, it is 
obvious that morphological change is not present. However, there is a slight dilution of 












           
           
Figure 5.15 Reflective and fluorescent overlay confocal images of CV-1 cells (a) 24hrs, 
(b) 48hrs, (c) 96hrs, (d) 250hrs post transfection. 
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5.4  Conclusion 
 
 In conclusion, CoFe2O4 – oligonucleotide conjugates have been delivered into 
mammalian cell lines through transfection. The cellular uptake proves to be at least four 
times higher than reported values demonstrating an increase in uptake efficiency. 
Observations indicated that magnetic nanoparticles pose no adverse effect to cells in vitro 
as cells continued to proliferate normally without morphological changes up to 250 hours 
post transfection. Synchronized movement in response to magnetic force clearly 
illustrated the potential of using magnetic nanoparticles such as CoFe2O4 as carriers for 
drugs, genes, and other therapeutic reagents for localized treatments. Additionally, 
magnetic nanoparticles coupled to oligonucleotides or other macromolecules can be used 
for sub-cellular tracking. If the source of a magnetic field is relatively close in proximity 
to the magnetic cargo, force approximation calculations show that there is great potential 
for guided delivery and localized treatment.  
 As mentioned in section 5.3.1, we did not verify the surface coverage of 
oligonucleotides on CoFe2O4 nanoparticles but predict that it will resemble the grafting 
density of benzoic acid on CoFe2O4 nanoparticles. Hence, it would be interesting to study 
the surface coverage of oligonucleotides on CoFe2O4 nanoparticles to determine the 
maximum packing density.  In addition, it would also be interesting to see how the uptake 
efficiency can be improved. The use of magnetic nanoparticles as chaperones for guided 
delivery and localized treatment has received a lot of attention but will require further 
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SURFACE MODIFICATION OF COBALT AND MAGNANESE SPINEL FERRITE 





 Spinel ferrites such as CoFe2O4 and MnFe2O4 have been crosslinked to 
oligonuceleotides and 1-H-Pyrazole-1-carboximide (HPC) through heterofunctional 
crosslinker, N-ε-Maleimidocaproic acid (EMCA). The magnetic nanoparticle – 
oligonucleotide conjugates have been transfected into African green monkey kidney cells 
(CV-1) and Henrietta Lack human cervical cancer cells (HeLa). The surface of the spinel 
ferrites conjugated to oligonucleotides is functionalized with epichlorohydrin and EMCA 
or with aminopropyltriethoxysilane (APTES) in conjunction with mercaptopropionic acid 
(MPA) and EMCA. The versatility of the crosslinker group permits the attachment of 
oligonucleotides terminated with thiols or amine. Confocal micrographs show that both 
crosslinking methods formed conjugates that can be transfected into mammalian cells. 
Fluorescent images of synchronized responses of cells to magnetic field purport the 
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internalization in cells.  Preliminary data indicating cellular uptake of magnetic 




 Magnetic nanoparticles have an evolving development in applications ranging 
from data storage to MRI contrast enhancement reagents to cell separation.1 The focus of 
cellular delivery of therapeutic reagents for cancer treatment has led to many 
developments entailing the use of magnetic nanoparticles as carriers for purposes of 
delivery and cellular trafficking (see chapter 5). However, in most situations, the 
magnetic nanoparticles used are either magnetite or maghemite. Cobalt spinel ferrite 
nanoparticles are stronger magnetic nanoparticles and respond to lower magnetic field 
strength. This is a pertinent factor considering the ultimate goal is to be able to magnetic 
guide drug delivery and magnetically localize the treatment within a region. Hence, we 
have focused our attention on using CoFe2O4 and other spinel ferrites as magnetic 
carriers. 
 Previously, we have demonstrated that CoFe2O4 can be conjugated to 
oligonucelotides for cellular uptake and magnetic manipulation using a commercially 
available crosslinker, SPDP (N-succinimidyl 3-[2-pyrithiol]propionate).2 Synchronized 
movements of cells in response to an external magnetic field as well as confocal and 
darkfield micrographs confirmed the incorporation of CoFe2O4 – oligonucleotides in cells 
and demonstrated the promising potential of CoFe2O4 as magnetic carriers for therapeutic 
reagents with magnetic control. Toxicity was not a focus in our previous study, but we 
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were able to demonstrate that CoFe2O4 did not induce any significant morphological 
change or interrupt the proliferation cycle. In this chapter, we explore different surface 
chemistry options for the attachment of oligonucleotides to CoFe2O4 and their 
applicability to different systems such as MnFe2O4. Specifically, we looked at a 
crosslinker that can form a thiol ester bond or an amide bond with oligonucleotides.  
 The possibility of using MFe2O4 (M = Co, Mn) nanoparticles as magnetic carriers 
for macromolecules has great potential and is illustrated in this chapter. Like most 
delivery systems, there is room for improvement. Current delivery method is often 
afforded through chemical transfection reagents that are toxic to cells if exposed for a 
long period of time. A better method is to modify the surface charge (e.g. using 1-H-
pyrazole-1-carboximide, “HPC”) of magnetic nanoparticles eliminating the requirement 





6.2.1 Preparation of Spinel Ferrite – Oligonucleotide conjugates 
 
 Cobalt spinel ferrite, CoFe2O4, was synthesized using a normal micelle method.3 
Briefly, a stoichiometric amounts of CoCl2⋅6H2O and FeCl2⋅4H2O were dissolved and 
added to a 1.5mM SDS (sodium dodecyl sulfate) surfactant solution at 10°C. 
Methylamine was then added at 10 °C and the solution was then heated to a temperature 
range of 55-65 °C f or 2 – 3 hrs. Nanoparticles were isolated with centrifugation followed 
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by several washes with 20:80 ethanol: distilled water. The final product was dried in air 
at 110 °C. Manganese spinel ferrite nanoparticles, MnFe2O4, were synthesized using a 
reverse micelle method.4 A stoichiometric amounts of Mn(NO3)2 and Fe(NO3)2 were 
dissolved in water then a 0.4 M NaDBS (sodium dodecylbenzenesulfonate) surfactant 
solution was added followed by an addition of a large volume of toluene. After 24 hrs of 
reaction time, NaOH solution was added dropewisely accompanied by vigorous stirring. 
Volume is then reduced by distillation and the concentrated suspension was washed with 
water and ethanol. The final product was heat treated at 350 °C for 12 hrs under He 
atmosphere.  
 Surface activation of CoFe2O4 and MnFe2O4 nanoparticles was accomplished by 
washing residual surfactants of the surface with concentrated NaOH. To attach thiol 
terminated oligonucleotides, CoFe2O4 and MnFe2O4 were reacted with epichlorohydrin 
fo l lowed by  amina t ion  wi th  NH 4 OH (Figure  6 .1)  o r  reac ted  wi th  1% 
aminopropytriethoxysilane (APTES; first step of Figure 6.2) to generate an amino moiety 
on the surface. Magnetic nanoparticles were then subjected to several washes with 
MesBupH (carbonate buffer; pH 4.5) then resuspended in a 25mM EMCA (ε-
maleimidocaproic acid)/EDC (1-[3-dimethylaminopropyl]-3-ethylcarbodiimide) in 
MesBupH. The suspension was sonicated for one hour then shaken overnight at room 
temperature. The functionalized magnetic nanoparticles were then magnetically separated 
and washed with PBS (phosphate buffered saline; pH 7.4) several times. Thiol terminated 
oligonucleotides (1 = 5’ HS – (CH2)6 – GTA AAA CGA CGG CCA GTG 3’) were 
reduced with Cleland’s reagent (immobilized dithiolthreitol) and added to the magnetic 



























































































































complimentary strand with a fluorescent tag ( 2 = CAC TGG CCG TCG TTT TAC 5’) 
was added to the solution and incubated above the melting temperature (Tm ≥ 65°C) for 
30 minutes and then allowed to cool to room temperature. Prior to transfection, the final 
products were magnetically separated and washed with PBS or OptiMem (a reduced 
serum media).   
 Alternatively, the chemistry of EMCA can be reversed for the attachment of 
amino terminated oligonucleotides to the surface of magnetic nanoparticles (see Scheme 
6.2). The residual surfactants on the surface are removed as described earlier. Magnetic 
nanoparticles (CoFe2O4 or MnFe2O4) were sonicated in a 1% APTES solution for 1 – 
2hrs. After magnetic separation and several washes with PBS, a 25mM MPA 
(mercaptopropionic acid) / 50mM EDC was added and then incubated at 60°C for 4-6hrs 
with periodic shaking. The thiol functionalized magnetic nanoparticles are then 
magnetically separated and washed several times with PBS. A 25mM EMCA/PBS 
solution is then added and allowed to react overnight. Once the crosslinker, EMCA, is 
attached to the magnetic nanoparticles, the suspension was subjected to several magnetic 
separations and washes with PBS before an amino terminated oligonucleotide 3 ( 3 =  5’ 
H2N – (CH2)6 – GTA AAA CGA CGG CCA GTG 3’) was introduced. Complimentary 
strands with a fluorescent tag were added to the suspension and allowed to hybridize 
above its Tm (Tm ≥ 65°C) for 30 minutes and then cooled to room temperature. 
Hybridization with oligo 2 ( 2 = CAC TGG CCG TCG TTT TAC 5’)  with described 
conditions yielded MFe2O4 – 3-2-FAM conjugates ( M = Co or Mn). Conjugates were 












































































6.2.2. Preparation of CoFe2O4 – HPC conjugates 
 
 Using the same schematic for amino attachment, HPA was conjugated to CoFe2O4 
(figure 6.3). Residual surfactant was removed with NaOH and CoFe2O4 was 
functionalized with APTES followed by MPA. Nanoparticles were then magnetically 
separated, rinsed with MesBupH, resuspended in 25mM HPC / 50mM EDC and then 
allowed to react overnight. The final product was then rinsed with distilled water and 
resuspended in distilled water for zeta potential measurements or resuspended in 









 Henrietta Lack’s cervical cells (HeLa) and African green monkey kidney cells 
(CV-1) were grown on coverslips in a 6-well plate in Dubelcco’s Modified Eagle’s 
Medium (DMEM) supplemented with 10% CBS (calf bovine serum) and 1% penicillin 
streptomycin glutamate to 60-70% confluency. Media was then removed and cells were 
washed with OptiMem. Lipofectamine™ was allowed to complex with MFe2O4 – 
oligonucleotide ( M = Co, Mn) then incubated with cells in OptiMem for 7-8 hours at 
37°C and 5% CO2. Transfection media was then removed through aspiration and replaced 
with a growth media and incubated for an additional day.  
 
6.2.4 Cellular Delivery of positively charged CoFe2O4 into CV-1 cells 
 
 African green monkey cells, CV-1, were grown on coverslips in a 6-well plate in 
DMEM supplemented with 10% CBS and 1% penicillin streptomycin glutamate to 60-
70% confluency. Media was removed prior to cellular delivery and cells were rinsed with 
OptiMem. Cobalt spinel ferrite – HPC complexes in OptiMem (estimated 125 µg/well of 
CoFe2O4 – HPC complex) were added to cells and incubated for eight hours at 37°C and 
5% CO2. OptiMem was then removed from the wells and replaced with a growth media 







 Post transfection, transfected cells to be examined by confocal microscopy are 
rinsed with PBS and fixed onto coverslips through standard fixation protocols using 4% 
p-formaldehyde in PBS for 15 minutes. Cells are then rinsed with PBS and mounted onto 
glass microscope slides with paramount G (preserves fluorescence). The confocal 
microscope used in these experiments is a Zeiss LSM 500 housed with an Argon laser.  
For monitoring the response of CoFe2O4 – HPC to an external magnetic field, cells are 
first rinsed with PBS, trypsinized, then resuspended in PBS. 
 
6.3. Results and Discussion 
 
6.3.1 Crosslinking of MFe2O4 ( M = Co, Mn) to oligonucleotides 
 
 Using a heterofunctional crosslinker, EMCA, oligonucleotides terminated with a 
thiol group or an amino group has been conjugated to MFe2O4. Surface functionalization 
with epichlorohyrin or APTES provided the amino moiety necessary for attachment of 
EMCA. To generate a thiol reactive surface, EMCA was added to amine functionalized 
MFe2O4 in the presence of EDC. To make the carboxylate terminus available for reaction, 
amino functionalized MFe2O4 nanoparticles were then further modified with MPA 
yielding a free sulfhydryl group. Subsequently, it was reacted with EMCA to form a thiol 
ester bond. An alternative method to leave the carboxylate terminus of EMCA is shown 
in Figure 6.4. We found that more attachment occurred following Figure 6.2 than Figure 
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6.4. This was evident due to the lack of fluorescence present when we used the protocol 
in Figure 6.4 was used. The lack of attachment is proposed to be attributed to the lack of 





Figure 6.4 Functionalization of magnetic nanoparticles (CoFe2O4 or MnFe2O4) with a 




6.3.2 Transfection of MFe2O4 – oligonucleotide conjugates ( M = Co, Mn) into  
cells 
 
 The incorporation of MFe2O4 – oligonucleotide conjugates into CV-1 and HeLa 
cells were primarily monitored by the fluorescent luminescence present in confocal z-
sectional images. Using two different crosslinking schematics and two different spinel 
ferrites, the versatility of spinel ferrite magnetic nanoparticles as carriers for therapeutic 
reagents has been illustrated.  As can be seen in figure 6.5-6.9, there is a general trend 
indicating lack of fluorescent luminescence at the bottom and top of the cell and a 
pronounced luminescence in the mid sections of the cells. This is a lucid indication that 
MFe2O4 – oligonucleotide conjugates are internalized by the cells and is supported by our 
previous study. These results are very similar to those shown in chapter 5 and is further 
purported by the synchronized movements of the cells in response to an external 
magnetic field (see Figure 10; heintz_eva_l_200412_phd_magneticmovement2.mpg). 
The ability to magnetically manipulate the magnetic nanoparticles in cells revealed the 
possibility of magnetically guided transport as well as localization of magnetic 
























































































































































































































Figure 6.10 Movie of synchronized movements of the cells in response to an external 




6.3.3 Surface charge modification with HPC and cellular delivery of CoFe2O4 – 
HPC 
 
 Many transfection or cell delivery facilitating reagents are toxic to cells after 
prolong exposure. From our control experiments in chapter 5, the transfection reagent did 
not complex with magnetic nanoparticles when oligonucleotides were not present on the 
surface of the particles. Hence, we explored the possibility of introducing magnetic 
nanoparticles without a “chaperone” by chemically altering the surface charge of the 
magnetic nanoparticles, CoFe2O4. Following the crosslinking schematics in Figure 6.3 we 
attached HPC to the surface of magnetic nanoparticles. At neutral pH, HPC has a net 
positive charge.5,6 Hence, CoFe2O4 – HPC complexes is presumably positively charged. 
Preliminary zeta potential measurements supported our hypothesis showing that native 
CoFe2O4 have a net negative surface charge (~ -3 mV) but when modified with HPA, 
there is a net positive surface charge (~ +4 mV). We were unable to use fluorescent 
microscopy or confocal microscopy to trace the location of CoFe2O4 – HPC 
intracellularly due to the lack of a fluorescence tag. Using an external magnet, we 
attempted to visualize the movement of CV – 1 cells with CoFe2O4 – HPC in response to 
external magnetic fields with bright field microscopy. From the micrographs in Figure 
6.10, the synchronized movement of cells, with incorporated CoFe2O4 – HPC, to an 
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external magnetic field confirms the uptake of CoFe2O4 – HPC. The mechanism of 
internalization is unclear at the moment. In cells, transport is either active or passive. 
Usually, positively charged species are transported through passive diffusion. Hence, we 






          
  
Figure 6.11 Brightfield micrographs of CV-1 cells with CoFe2O4 – HPC moving with an 
external magnetic field.  





 Cobalt and Manganese spinel ferrites conjugated to oligonucleotides have been 
successfully transfected into CV-1 and HeLa cells. Two different points of attachment 
utilizing one common crosslinker were explored. Comparable results were found with 
both attachment schematics. Cells movement corresponding to an external magnetic field 
revealed the possibility of magnetic guidance and localization. Surface modification of 
magnetic nanoparticles with HPC provided an alternate method to deliver magnetic 
nanoparticles into cells without facilitating reagents. This study demonstrated the various 
possibilities of tailoring the surface of magnetic nanoparticles for subsequent cellular 
delivery and explored spinel systems other than CoFe2O4. All experiments studied here 
were done in vitro and it would be interesting to resolve the parameters involved for in 
vivo experiments. Progress towards this direction will not only involve toxicity but also 
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CONCLUSIONS AND FUTURE WORK 
 
 
7.1 Tunability of magnetic nanoparticles 
  
 In this thesis, the synthesis and characterization of samarium doped cobalt spinel 
ferrites was discussed. Data showed that by introducing small amounts of samarium the 
magnetic properties of the doped spinel ferrite dramatically differs from the native 
CoFe2O4. The similarity between the X-ray diffraction pattern of CoFe2O4 and the 
samarium doped cobalt spinel ferrite, CoSmxFe2-x, revealed that doping of Sm3+ did not 
change the lattice constant and retained the spinel phase. Although neutron studies were 
not conducted due to the large absorption cross sections of Sm3+ ions, data from, previous 
studies using La3+ was used demonstrate that Sm3+ is homogenously doped into the 
octahedral site of a spinel ferrite unit cell. The high coercive forces of Sm3+ ions comes 
from the large magnetocrystalline anisotropy (due to the high spin-orbit coupling). Hence, 
when doped into cobalt spinel ferrites, an increase in coercitivity was observed. When 
comparing between samples with different Sm3+ concentrations, a negligible change in 
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coercitivity and saturation magnetization was observed and is postulated to be attributed 
to the small change in Sm3+ concentration. Relative to each other, the addition of the 
coercive force to the spinel system is not as pronounced when comparing doped samples. 
By keeping the composition constant and varying the size, magnetic properties were also 
altered. Of particular interest is in the non-linear trend of coercitivity change. There was 
an initial increase in coercitivity with increase in size then coercitivity began to decrease 
with increasing size. While we propose that the initial increase in coercitivity is from 
coherent rotation of moments, the eventual decrease in coercitivity is unclear. We can 
only speculate that it is due to other surface effects.  
 We have demonstrated through this systematic study that it is possible to dope 
relatively large lanthanide ions into spinel ferrite system. Because of the dramatic change 
in magnetic properties between the native CoFe2O4 and the Sm3+ doped spinel ferrites, , 
CoSmxFe2-x, the tunability of magnetic nanoparticles have been demonstrated. There are 
many data that we cannot conclusively interpret at this time. By studying the effects of 
doping other lanthanide ions in a systematic manner, a comparison can be made between 
each dopant and a more conclusive interpretation can be presented. 
 
7.2 Cellular Uptake of Magnetic Nanoparticles 
  
 In chapter 5 and 6, different approaches to modify the surface of MFeO4 (M = Co, 
Fe) for cellular uptake was illustrated. Using commercially available heterofunctional 
crosslikners like SPDP and EMCA, thiol terminated or amine terminated 
oligonucleotides were attached to MFeO4 nanoparticles. Using transfection reagents such 
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as Lipofectamine™, MFeO4 – oligonucleotide conjugates were taken up by cells through 
endocytosis. Darkfield microscopy data in conjuction with confocal microscopy 
confirmed that MFeO4 – oligonucleotide conjugates were indeed incorporated into the 
cell. Synchronized movement of transfected cells in response to a magnetic field further 
supported the internalization of MFeO4 – oligonucleotide conjugates and demostrated 
magnetic control of MFeO4 nanoparticles in cells. From force calculations (Appendix B), 
there is a large discrepancy between the magnetic force experienced by cells and the 
hemadynamic force experienced by a cell. Based on calculated force values, it would be 
very difficult to guide MFe2O4 nanoparticles in a flowing system. However, previous 
experimental data showed that it is possible to stop MFe2O4 in a flowing system with 
about 300G. Clearly, there are many factors that were not considered in the force 
estimation calculations. Future work such as monitoring the magnetic response of cells 
transfected with magnetic nanoparticles in a flowing system as well as detail mathematic 
modeling of all the hemadynamic parameters involved may help identify if magnetic 
control in vivo is truly possible.  
 When the surface charge of CoFe2O4 nanoparticles were modified with HPC, 
surface charge was altered. Internalization of CoFe2O4 – HPC was demonstrated by the 
movements of cells in response to an external magnetic field. Although the mechanism 
from which  CoFe2O4 – HPC is unclear at the moment, it is proposed to be through 
passive diffusion. Surface density of HPC on CoFe2O4 was not examined but may play an 
important role in the uptake efficiency by cells. By examining the surface coverage of  
HPC and the uniformity of the attachment of HPC, better understanding of how to 
improve the cellular uptake of magnetic nanoparticles can be afforded.  
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7.3 Magnetic Nanoparticles Coupled to Viruses 
 
 We made an attempt to conjugate CoFe2O4 to Cowpea Mosaic Virus (CPMV) 
through surface modification of CoFe2O4 with EMCA (see Appendix B). A preliminary 
reconstructed three dimensional TEM image of the native CPMV capsid was compared to 
the, presumably, CoFe2O4 bound CPMV capsid. There was a clear difference between the 
two images. We speculated that the attachment was successful but more data is required 
to confirm the attachment. CPMV is capable of expressing foreign epitopes. Conjugating 
CPMV to magnetic nanoparticles for magnetically guided delivery into the circulatory 
system is worth pusuing to see if an immunoresponse would be prompted. Cowpea 
mosaic viruses are only infectious towards plants, hence, they are great DNA carriers. 
With the advancement of gene therapy, there is a lot of advantage of coupling magnetic 
nanoparticles to CPMV. For example, an active gene can be carried in the capsid of 
CPMV that is attached to magnetic nanoparticles. Using a magnetic field, may possible to 
guide the CPMV-magnetic nanoparticle conjugate close to the target site to unload the 
active gene. As mentioned, the data collected thus far is preliminary and this system will 




 In conclusion, the tunability of cobalt spinel ferrites were explored as was their 
applications in cell biology. From synthesis to characterization to application, data 
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showed the versatility of magnetic nanoparticles. We are far from pursuing in vivo 
experiments but data collected throughout this thesis facilitates the progress towards in 












MAGNETIC FORCE AND HEMADYNAMIC FORCE ESTIMATION 
 
 
A.1 Magnetic Gradient Determination 
 
 The magnetic field of the Nd-Fe-B magnet used in Chapter 5 and 6 was measured 
at various distances from the probe to the magnet using a Lakeshore 410 Gaussmeter (see 
table A.1). The magnetic field is proportional to the distance by 
 
                   H ∝ 1/r3                                                          (A.1) 
 
where H is the magnetic field and r is the distance in meters. 1,2 Based on our 
experimental measurements, the data correlates well with the distance relationship (see 
figure A.1). Using the equation 
  
         y = 0.0111/ x2.8443                          (A.2) 
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at 5.08cm (distance used experimentally between cell sample and magnet), the magnetic 
field is estimated to be 53.2 G, comparable to those reported in literature.3  Choosing the 
magnetic field value at the source (3315G) and at 5.08 cm (53.2G), the magnetic gradient 




Table A.1 Magnetic Flux change with distance 
Approximate Distance From Magnet (m) Magnetic Field Measured (G) 
1.0 x 10-2 2680 
2.0 x 10-2 846 
3.0 x 10-2 387 
4.0 x 10-2 180 
5.0 x 10-2 69.9 
6.0 x 10-2 21.1 
7.0 x 10-2 12.6 
8.0 x 10-2 9.20 
9.0 x 10-2 14.7 
1.0 x 10-1 5.50 
1.2 x 10-1 3.60 






























A. 2 Magnetic Force Experienced By Cells  
 
 The amount of magnetic force exerted on one cell by a magnet can be estimated 
by multiplying the magnetic moment of the particles in one cell by the magnetic 
gradient.1,4 Given that the diameter of the magnetic nanoparticles is 10.02 nm, the volume 
can be calculated by 
 
             Vnp = 4/3πr3                                                (A.3) 
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where Vnp is the volume of each nanoparticle and r is the radius of the nanoparticle. By 
multiplying the Vnp by the number particles per cell (4.44 x 107 particles/cell), we get a 
total volume of 2.34 x 10-17 cm3. The density of CoFe2O4 has been estimated to be 5.29 
g/cm3, hence there are approximately 1.24 x 10-16 g of CoFe2O4 in each cell. With a Ms of 
76.7604 emu/g (determined experimentally), we can estimate the total moment present in 
each cell by 
 
                   Ms x g nanoparticles in each cell                           (A.4) 
 
giving us 9.52 x 10-15 emu (9.52 x 10-18 A⋅m2). Using the magnetic gradient of 6.42 T/m, 
the magnetic force exerted experienced per cell is 61.1 x 10-17 N.  
  
 
A.3 Hemadynamic Force Experienced By Cells 
 
 Hemadynamic forces are forces required to circulate blood through the circulatory 
system.5,6 It counteracts the magnetic forces on particles as they flow through the 
bloodstream. When the particle size, is less than 100 µm the Reynolds number (Re) is 
given as 
 
         Re = ρvd / µ        (A.5) 
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where ρ is the density of the medium (blood), v is the velocity of flow, and µ is the 
viscosity of the medium.7 If Re is relatively small, then the primary forces experienced by 
particles (cells) are primarily inertial forces.6 Since viscous force is governed by Stoke’s 
Law at small Re values, we estimate the hemadynamic force by 
 
        F = 6πηvr         (A.6) 
 
where η is the viscosity of blood (4.0 x 10-3 kg/m⋅s)5, v is the velocity of blood (~ 4.7 x 
10-4 m/s capillary flow)5, and r is the radius of the cell (40µm). From equation A.6, we 
calculated that the hemadynamic force experienced by one cell in a capillary flow would 
be 1.42 nN.  
  
A.4 Conclusion  
 
 Experimentally, we found when the distance between the magnet and the cell 
suspension is about 10-15 cm away, the magnetic movement halted. The most dramatic 
movement of cells occurs when the distance between the magnet and the cell suspension 
is less than 5.08cm. Using a magnetic gradient of 6.42 T/m, the magnetic force 
experience per cell is estimated to be 61.1 x10-17 N. The hemadynamic force 
counteracting the magnetic force on a cell (with magnetic nanoparticle incorporated) in a 
flowing system such as a capillary was estimated to be 1.42 nN.  
 With such a large discrepancy between the hemadynamic force and the magnetic 
force, magnetic localization of cells (with internalized magnetic nanoparticles) flowing in 
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a capillary is not likely to occur. However, we have previously shown that magnetic 
nanoparticles (25nm) conjugated to proteins flowing in a carrier fluid with a 5cps 
viscosity at 20cm/s in a capillary can be captured with an external magnet.8 Clearly, the 
system is much more complicated then what is presented here. To truly understand the 
complicated factors involved, models and calculations encompassing factors such as 
pressure, turbulence of flow, attractive forces, change in viscosity, and many other 
variants has to be considered. If we completely rely on the calculations presented here 
then we can postulate that an increase in size of the nanoparticle and an increase in 
magnetic field applied (e.g. 1.0 T) with a magnet at closer proximity (less than 1 cm) may 
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 An attempt to couple cobalt ferrite magnetic nanoparticles to Cowpea mosaic 
virus (CPMV),a plant virus, capable of expressing foreign antigenic epitopes, has been 
made. Cobalt spinel ferrite nanoparticles modified with ε-maleimido caproic acid are 
used to probe for free sulfhydryl groups present at the interior of the CPMV capsid. 
Preliminary data of three dimensionally reconstructed cryo-transmission electron 
micrographs showed that the nanoparticles are likely to be bound to the pores of the viral 
capsid. The versatility of the virus with the addition of magnetic properties from the 
magnetic nanoparticles may lead to many potential biological applications including 






 The application spectrum of nanoparticles extends across several fields of science 
and will continue to expand with time. Focusing on magnetic nanoparticles, application 
such in data storage,1-4 ferrofluids,5-8 magnetic resonance imaging9-12, cell separation13,14, 
and cellular trafficking15-19 have all been demonstrated. Recently, the induced self-
assembly of magnetic nanoparticles through viruses has also been addressed as a means 
of detecting viral particles through magnetic resonance imaging.20,21 Although there are 
numerous publications on virus identification, viral applications, and viral genome 
manipulation, few are focused on the applications of virus coupled to magnetic 
nanoparticles. Our study here focuses on expanding the bio-applications of magnetic 
nanoparticles by coupling cowpea mosaic virus to cobalt spinel ferrite to investigate on 
potential uses.  
 Cowpea mosaic virus, a plant virus in the Como genera of the Comoviridae share 
similar structural organization, DNA and RNA sequence, and replication processes to 
mammalian picornaviruses such as poliovirus.22  The primary host of CPMV is Vigna 
unguiculata and when infected with, CPMV can cause vein yellowing, mosaic formation, 
and deformation of leaves.23,24 Recently, the crystal structure of CPMV was resolved at 
2.8Å resolution by Lin and co-workers.25 The capsid contains 60 copies of a large protein 
and 60 copies of a small coat protein that assembles into an icosahedral symmetry. 
Cowpea mosaic virus can express foreign epitopes when its wild type sequence of CPMV 
is removed and replaced with epitopes of foreign viruses such as the human rhinovirus 
type 14 (HRV-14) or the human immunodeficiency virus type 1 (HIV-1) 26 The structural 
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symmetry of CPMV, the stability of CPMV at a broad pH range of 3-9 at room 
temperature, the ease of producing large quantities of CPMV, and the ability of CPMV to 
express foreign epitopes without infecting mammalian hosts with its own infectivity 
makes it an attractive system to study as gene carriers and self assembly models.  
 Recently, the versatility of CPMV has been demonstrated through several 
variations of applications. Raja and co-workers attached polyethylene glycol onto the 
surface of CPMV to monitor changes in primary immunogenic responses.27 Smith et. al. 
have immobilized CPMV onto gold substrates through dip-pen nanolithography (DPN) 
chemospecifically minimizing adsorption of nonspecific proteins that may serve as a 
ligand-receptor model and may have potential uses as biosensors.28 In a separate study, 
Raja and co-workers have also demonstrated that carbohydrates can be decorated on the 
capsid of CPMV.29 The potential of CPMV as a nanoscale building block was addressed 
as gold nanoparticles were attached to mutant CPMVs forming a nice assembly.30,31 In 
this chapter, preliminary data on the coupling of magnetic nanoparticles to CPMV will be 





 Magnetic nanoparticles, CoFe2O4, between 3.7nm and 4.2nm were prepared using 
a normal micelle method.32 Briefly, stoichiometric amounts of CoCl2 ⋅ 6 H2O and FeCl2 ⋅ 
4 H2O were mixed together with 1.5mM sodium lauryl sulfate (SDS). After nucleation, 
the pH was increased with methylamine. The suspension is then heated to 65°C to allow 
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growth of the magnetic nanoparticles. Nanoparticles were isolated through centrifugation 
and dried at 110 °C in air. The size and phase of the sample is then verified with powder 
XRD before use.  
 Before attachment to the Cowpea Mosaic Virus, modification to the surface of 
CoFe2O4 was made (see Figure B.1). Residual surfactant was removed by stirring 
CoFe2O4 in concentrated NaOH. After several washes with distilled water followed by 
magnetic separation after each wash, the surface was then functionalized with 
epichlorohydrin in 5M NaOH at 60°C for two hours followed by amination with NH4OH. 
The amine functionalized magnetic nanoparticles were then washed with DMSO several 
times followed by magnetic separation after each wash. A commercially available 
heterofunctional crosslinker, N-ε-Maleimidocaproic acid (EMCA), was attached to the 
surface of CoFe2O4 through amide bond formation in the presence of 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide (EDC). Maeimide functionalized magnetic 
nanoparticles(~210 µg) were reacted with thiol groups in the CPMV capsid (~100µg) in 
PBS or 20% DMSO/PBS with a reducing agent, dithiothreitol (DTT). The resulting 
CoFe2O4 – CPMV is then characterized with cryo-TEM and a three-dimensional image is 




























































B.3 Results and Discussion 
 
 Surface modification of CoFe2O4 with crosslinker ε-Maleimidocaproic acid 
provided the attachment points between the Cowpea Mosaic virus and CoFe2O4 magnetic 
nanoparticles.  Three-dimensional reconstruction of the cryo-TEM image of the native 
CPMV and that of CoFe2O4 bound to CPMV can be seen in Figure B.2. Clearly, the two 
images are different. From the native structure, you can see pores on the capsid. These 
pores are then filled with cone shaped structures, presumably cobalt spinel ferrites. There 
are cysteine groups in the interior of CPMV one of which is close to exterior of CPMV 
capsid. Cobalt spinel ferrites-EMCA nanoparticles presumably are binding at the pores of 
the capsid. At this time, there is not enough data to confirm the binding between the 
nanoparticles and the viral capsid. Since similar structures such as gold nanoparticle 
bound mutant CPMV, seen in Figure B.3,22,31 have been observed before,  it likely that 







Figure B.2 Three dimensionally reconstructed cryo-TEM image of the (a) native CPMV 






Figure B.3 (a) Three dimensional reconstructed cryo-TEM image of mutant CPMV 
labeled with 1.45nm gold nanoparticles. (b) Difference electron density map showing the 
gold nanoparticles and the nucleic acids. (c) Superimposed image of a pentametric 
section of the difference electron density map and the atomic model of CPMV.22,31 
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B.4 Conclusion  
 
 In this study we focused on coupling of CoFe2O4 to CPMV. Data shown thus far 
is preliminary and will require further systematic investigation to confirm the binding of 
CPMV to CoFe2O4. The conjugation chemistry described here is straightforward and 
should be applicable to different magnetic nanoparticles such as MnFe2O4 as well as 
other viral systems such as the poliovirus. We know that there are only a few internal 
cysteine groups available for anchoring magnetic nanoparticles. Hence, the reactivity 
between magnetic nanoparticles and CPMV may be enhanced by using mutant CPMVs 
that contain multiple cysteine insertions. Added cysteine residues will protrude to the 
exterior of the capsid providing more anchoring points. Although data described here is 
preliminary, the foundation for a systematic study to probe into different crosslinking 
chemistry as well as potential applications such as magnetically guided gene transfer, has 
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